Alastair Burt

Professor Alastair Burt

Emeritus Professor

Health and Medical Sciences Faculty Office

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.


He was born in Dunfermline, Scotland and is a graduate of the University of Glasgow where he obtained a BSc in Pathology with first class Honours in 1979, MBChB with commendation in 1981 and MD with Honours and the Bellahouston medal in 1991.

Upon graduation he was a junior house officer in general medicine with Professor Sir Abraham Goldberg and junior house officer in general surgery with Professor Sir David Carter. He subsequently took up training in surgical pathology under the tutorage of Professor Sir Roddy MacSween. During this time he developed expertise in diagnostic pathology of the liver and a keen interest in pathogenesis of liver disease and in particular mechanisms of liver fibrosis. In 1985-86 he spent time in the lab for cell biology and histology at Free University of Brussels under the direction of Professor Eddie Wisse.

On return to the UK and on completion of his postgraduate training in Surgical Pathology he moved to the University of Newcastle upon Tyne to become Senior Lecturer in Pathology and Honorary consultant Histopathologist. He was promoted to a personal Chair in Hepatopathology in 1995 and then the established Chair of Pathology in 1998. He became Dean of Clinical Medicine at the University of Newcastle upon Tyne in 2005.

He moved to South Australia in January 2013 to take up the post of Dean of Medicine and Head of the School of Medicine. In August 2014 he became acting Executive Dean of the Faculty of Health Sciences and was appointed to the substantive role in December 2014. He continues to maintain a research interest in liver disease and is Editor in Chief of the principal international text book in his field, MacSweens Pathology of the Liver, now into its 7th edition. In addition he is Editor in Chief of the peer reviewed journal, Histopathology.

Research Interests

Professor Burt has a long standing interest in the pathogenesis of liver fibrosis.  This is an important part of progressive liver disease and an essential component for the development of cirrhosis.  He played a pivotal role in establishing the principal cell type involved in fibrogenesis is the hepatic stellate cell and was the first to characterise their  cell kinetics in the response to injury establishing that there is not only proliferation of these cells in response to necrosis but a phenotypic modulation to myofibroblast-like cell.  He was among the first to utilise isolated cell preparations of stellate cells to characterise in vitro properties such as collagen production and to examine the effects of cytokines responsible for activating these cells.  In parallel with basic studies of fibrogenesis he has been involved in applied studies of surrogate markers of fibrogenesis and this has led to the development of algorithms of serum markers that represent an effective means of monitoring fibrosis in individual patients.  He has attracted grant funding of over $8.5 million including awards from the MRC, Wellcome Trust and NIH.  He played a key role on an FP7 EU grant on fatty liver disease leading a consortium tasked with redefining steatohepatitis for diagnostic epidemiological purposes.  He has been editor or co-editor of eight textbooks, 22 book chapters and over 190 scientific publications.  He has been supervisor or co-supervisor for 17 HDR students.  He was a member of one of the panels of the UK RAE 2008 and was appointed to the REF 2014 exercise before moving to Australia.

He continues to be clinically active and has an appointment as a senior consultant anatomical pathologist with SA Pathology with responsibility for gastrointestinal and liver surgical pathologies. He has full registration with AHPRA.  He is one of the senior members of the International Hepatopathology Group (Gnomes) an organisation which has been in existence since 1967 and which has been responsible for major classifications and diagnostic approaches to liver disease.

    Expand
  • Appointments

    Date Position Institution name
    2019 Emeritus Professor University of Adelaide
    2014 - 2019 Executive Dean University of Adelaide
    2014 - 2014 Acting Executive Dean University of Adelaide
    2013 - 2014 Dean of Medicine and Head of School University of Adelaide
    1998 - 2012 Established Chair of Pathology and Dean of Clinical Medicine (from 2005) University of Newcastle upon Tyne
    1995 - 1998 Personal Professorship in Hepatopathology University of Newcastle upon Tyne
    1989 - 1995 Senior Lecturer in Pathology University of Newcastle upon Tyne, Royal Victoria Infirmary
    1986 - 1989 Registrar and Senior Registrar in Pathology Western Infirmary
    1986 - 1986 Honorary Clinical Teacher University of Glasgow
    1985 - 1986 Peel Travelling Research Fellow Free University of Brussels
    1982 - 1985 Senior House Officer/Registrar in Pathology Western Infirmary
    1982 - 1982 Junior House Officer in General Surgery Royal Infirmary
    1981 - 1982 Junior House Officer in General Medicine Western Infirmary
  • Awards and Achievements

    Date Type Title Institution Name Country Amount
    2014 Fellowship Royal College of Pathologists of Australasia
    2009 Fellowship Royal College of Physicians United Kingdom
    2009 Fellowship Fellowship of the Royal College of Physicians (London)
    1997 Fellowship Fellowship of the Royal College of Pathologists
    1997 Fellowship Royal College of Pathologists
    1996 Fellowship Institute of Biologists
    1996 Fellowship Fellow of the Institute of Biologists (now Fellow of the Royal Society of Biologists)
    1993 Award Canterbury Medical Foundation Research Award University of Otago
    1993 Achievement CL Oakley Lectureship Pathological Society of Great Britain and Ireland
    1992 Award Bellahouston Medal University of Glasgow
    1981 Award Agnes Cameron and Mary Margaret Isabel Ure Prize
    1981 Award John W Weir Prize
    1980 Award Glasgow University Medical Chirurgical Society Calman Trophy
  • Education

    Date Institution name Country Title
    1991 University of Glasgow United Kingdom M.D. with Honours and Medal
    1981 University of Glasgow United Kingdom M.B. Ch.B. with Commendation
    1979 University of Glasgow United Kingdom B.Sc. in Pathology with First Class Honours
  • Certifications

    Date Title Institution name Country
    2015 Fellowship of the Australian Academy of Health and Australian Academy of Health and Medical Sciences
    2015 Fellowship of Academy of Medical Educators Academy of Medical Educators
    2014 Fellowship of the Royal College of Pathologists of Royal College of Pathologists of Australasia
    2009 Fellowship of the Royal College of Physicians Royal College of Physicians
    2007 Foundation Member Academy Medical Educators
    1997 Fellowship of the Royal College of Pathologists Royal College of Pathologists
    1996 Fellowship of the Royal Society of Biologists Royal Society of Biologists
    0 Membership Royal College of Pathologists
    0 Membership Institute of Biologists
    Expand
  • Journals

    Year Citation
    2019 Cheng Tao Pu, L. Z., Chiam, K. H., Yamamura, T., Nakamura, M., Berzin, T. M., Mir, F. F., . . . Singh, R. (2019). Narrow-band imaging for scar classification: from conception to multicenter validation.. Gastrointestinal endoscopy.
    DOI
    2019 Houghton, D., Zalewski, P., Hallsworth, K., Cassidy, S., Thoma, C., Avery, L., . . . Trenell, M. (2019). The degree of hepatic steatosis associates with impaired cardiac and autonomic function. Journal of Hepatology, 70(6), 1203-1213.
    DOI Scopus2 WoS2
    2019 Brial, F., Le Lay, A., Hedjazi, L., Tsang, T., Fearnside, J., Otto, G., . . . Gauguier, D. (2019). Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment. Scientific Reports, 9(1), 10 pages.
    DOI
    2019 Zorron Cheng Tao Pu, L., Lu, K., Ovenden, A., Rana, K., Singh, G., Krishnamurthi, S., . . . Singh, R. (2019). Effect of time of day and specialty on polyp detection rates in Australia. Journal of Gastroenterology and Hepatology (Australia), 34(5), 899-906.
    DOI
    2019 Kobayashi, H., Enomoto, A., Woods, S., Burt, A., Takahashi, M., & Worthley, D. (2019). Cancer-associated fibroblasts in gastrointestinal cancer. Nature Reviews Gastroenterology and Hepatology, 16(5), 282-295.
    DOI Scopus4 WoS3 Europe PMC3
    2018 Burt, A. (2018). A further change of the guard. Histopathology, 73(6), 876-877.
    DOI
    2018 Burt, A., Alves, V., Bedossa, P., Clouston, A., Guido, M., Hübscher, S., . . . Ellis, D. (2018). Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 73(3), 369-385.
    DOI Scopus2 WoS2
    2018 Shalapour, S., Lin, X., Bastian, I., Brain, J., Burt, A., Aksenov, A., . . . Karin, M. (2018). Erratum to: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity (Nature, (2017), 551, 7680, (340-345), 10.1038/nature24302). Nature, 561(7721), E1.
    DOI
    2017 Shalapour, S., Lin, X. -J., Bastian, I., Brain, J., Burt, A., Aksenov, A., . . . Karin, M. (2017). Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature, 551(7680), 340-345.
    DOI Scopus53 WoS49 Europe PMC38
    2017 Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C., Lahat, A., . . . Jurk, D. (2017). Cellular senescence drives age-dependent hepatic steatosis. Nature Communications, 8, 15691-1-15691-12.
    DOI Scopus113 WoS106 Europe PMC70
    2017 Burt, A. (2017). Annual review issue: surgical pathology of 21st century medicine. Histopathology, 70(1), 3.
    DOI
    2017 McPherson, S., Hardy, T., Dufour, J., Petta, S., Romero-Gomez, M., Allison, M., . . . Anstee, Q. (2017). Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. American Journal of Gastroenterology, 112(5), 740-751.
    DOI Scopus62 WoS48 Europe PMC27
    2017 Lackner, C., Bataller, R., Burt, A., Miquel, R., Schuppan, D., Tiniakos, D., & Trauner, M. (2017). Fibrosis evaluation by transient elastography in alcoholic liver disease: is the histological scoring system impacting cutoff values?. Hepatology, 65(5), 1758-1761.
    DOI Scopus2 WoS2 Europe PMC1
    2017 McPherson, S., Wilkinson, N., Tiniakos, D., Wilkinson, J., Burt, A., McColl, E., . . . Day, C. (2017). A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. PLoS ONE, 12(4), e0175717-1-e0175717-17.
    DOI Scopus12 WoS10 Europe PMC7
    2017 Houghton, D., Thoma, C., Hallsworth, K., Cassidy, S., Hardy, T., Burt, A., . . . Trenell, M. (2017). Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 15(1), 96-102.e3.
    DOI Scopus32 WoS28 Europe PMC18
    2016 Alhasan, S., Haugk, B., Ogle, L., Beale, G., Long, A., Burt, A., . . . Reeves, H. (2016). Sulfatase-2: A prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma. British Journal of Cancer, 115(7), 797-804.
    DOI Scopus3 WoS2 Europe PMC2
    2016 Munteanu, M., Tiniakos, D., Anstee, Q., Charlotte, F., Marchesini, G., Bugianesi, E., . . . Mercadier, A. (2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Alimentary Pharmacology and Therapeutics, 44(8), 877-889.
    DOI Scopus17 Europe PMC15
    2016 Singh, R., Tao Pu, L., Koay, D., & Burt, A. (2016). Sessile serrated adenoma/polyps: Where are we at in 2016?. World Journal of Gastroenterology, 22(34), 7754-7759.
    DOI Scopus11 WoS9 Europe PMC4
    2016 Liew, V., Chapman, M., Nguyen, N., Cousins, C., Plummer, M., Chapple, L., . . . Deane, A. (2016). A prospective observational study of the effect of critical illness on ultrastructural and microscopic morphology of duodenal mucosa. Critical Care and Resuscitation, 18(2), 102-108.
    Scopus3 WoS5 Europe PMC4
    2016 Dunn, L., Burt, A., Hayes, N., & Griffin, S. (2016). Columnar metaplasia in the esophageal remnant after esophagectomy: a common occurrence and a valuable insight into the development of Barrett esophagus. Annals of Surgery, 264(6), 1016-1021.
    DOI Scopus4 WoS4 Europe PMC3
    2016 Burt, A. (2016). From This Month's Histopathology. Histopathology, 68(4), 473-474.
    DOI
    2016 Shi, Z., Chen, W., Taylor, A., & Burt, A. (2016). Elevated transaminase levels among overweight adolescents in eastern China. Acta Paediatrica, International Journal of Paediatrics, 105(12), e593-e599.
    DOI
    2015 McPherson, S., Hardy, T., Henderson, E., Burt, A., Day, C., & Anstee, Q. (2015). Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. Journal of Hepatology, 62(5), 1148-1155.
    DOI Scopus271 WoS264 Europe PMC177
    2015 Burt, A., Lackner, C., & Tiniakos, D. (2015). Diagnosis and assessment of NAFLD: definitions and histopathological classification. Seminars in Liver Disease, 35(3), 207-220.
    DOI Scopus42 WoS41 Europe PMC23
    2015 Cornell, L., Munck, J., Alsinet, C., Villanueva, A., Ogle, L., Willoughby, C., . . . Reeves, H. (2015). DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival. Clinical Cancer Research, 21(4), 925-933.
    DOI Scopus32 WoS33 Europe PMC24
    2015 Bedossa, P., Burt, A., Brunt, E., Callea, F., Clouston, A., Dienes, H., . . . Wanless, I. (2015). Well-differentiated hepatocellular neoplasm of uncertain malignant potential - Reply. Human Pathology, 46(4), 635-636.
    DOI Scopus1 WoS2 Europe PMC1
    2014 Bedossa, P., & FLIP Pathology Consortium. (2014). Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology, 60(2), 565-575.
    DOI Scopus147 WoS142 Europe PMC94
    2014 Probert, P., Ebrahimkhani, M., Oakley, F., Mann, J., Burt, A., Mann, D., & Wright, M. (2014). A reversible model for periportal fibrosis and a refined alternative to bile duct ligation. Toxicology Research, 3(2), 98-109.
    DOI Scopus7 WoS8
    2014 McPherson, S., Henderson, E., Burt, A., Day, C., & Anstee, Q. (2014). Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 60(5), 1055-1062.
    DOI Scopus29 WoS28 Europe PMC22
    2014 Brunt, E., Gouw, A., Hubscher, S., Tiniakos, D., Bedossa, P., Burt, A., . . . Wanless, I. (2014). Pathology of the liver sinusoids. Histopathology, 64(7), 907-920.
    DOI Scopus23 WoS22 Europe PMC19
    2014 Liu, Y., Reeves, H., Burt, A., Tiniakos, D., McPherson, S., Leathart, J., . . . Anstee, Q. (2014). TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nature Communications, 5(1), 4309-1-4309-6.
    DOI Scopus214 WoS193 Europe PMC138
    2014 Liu, Y., Patman, G., Leathart, J., Piguet, A., Burt, A., Dufour, J., . . . Anstee, Q. (2014). Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Journal of Hepatology, 61(1), 75-81.
    DOI Scopus162 WoS167 Europe PMC103
    2014 Masson, S., Emmerson, I., Henderson, E., Fletcher, E., Burt, A., Day, C., & Stewart, S. (2014). Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease. Liver International, 34(2), 235-242.
    DOI Scopus14 WoS13 Europe PMC7
    2013 Elsharkawy, A., Schwab, U., McCarron, B., Burt, A., Daly, A., Hudson, M., & Masson, S. (2013). Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser. Journal of Clinical Virology, 58(1), 331-333.
    DOI Scopus9 WoS7 Europe PMC6
    2013 Thompson, E., Burt, A., Barker, C., Kirby, J., & Brain, J. (2013). Development of a robust protocol for gene expression analysis using formalin-fixed, paraffin-embedded liver transplant biopsy specimens. Journal of Clinical Pathology, 66(9), 815-818.
    DOI Scopus2 WoS3 Europe PMC2
    2013 Brain, J., Robertson, H., Thompson, E., Humphreys, E., Gardner, A., Booth, T., . . . Kirby, J. (2013). Biliary epithelial senescence and plasticity in acute cellular rejection. American Journal of Transplantation, 13(7), 1688-1702.
    DOI Scopus16 WoS14 Europe PMC9
    2013 Bedossa, P., Burt, A., Brunt, E., Callea, F., Clouston, A., Dienes, H., . . . Wanless, I. (2013). Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category. Human Pathology, 45(3), 658-659.
    DOI Scopus23 WoS25 Europe PMC18
    2013 Robinson, S., Mann, J., Vasilaki, A., Mathers, J., Burt, A., Oakley, F., . . . Mann, D. (2013). Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. Journal of Hepatology, 59(2), 318-326.
    DOI Scopus54 WoS49 Europe PMC36
    2013 McPherson, S., Anstee, Q., Henderson, E., Day, C., & Burt, A. (2013). Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?. European Journal of Gastroenterology & Hepatology, 25(6), 652-658.
    DOI Scopus35 WoS36 Europe PMC22
    2013 Hardy, T., Wells, C., Kendrick, S., Hudson, M., Day, C., Burt, A., . . . Stewart, S. (2013). White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers. BMC Gastroenterology, 13(1), 55-1-55-5.
    DOI Scopus25 WoS24 Europe PMC16
    2013 Fairhall, E., Wallace, K., White, S., Huang, G., Shaw, J., Wright, S., . . . Wright, M. (2013). Adult human exocrine pancreas differentiation to hepatocytes - potential source of a human hepatocyte progenitor for use in toxicology research. Toxicology Research, 2(1), 80-87.
    DOI Scopus10 WoS9
    2013 Moles, A., Sanchez, A., Banks, P., Murphy, L., Luli, S., Borthwick, L., . . . Oakley, F. (2013). Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response. Hepatology, 57(2), 817-828.
    DOI Scopus19 WoS18 Europe PMC13
    2013 Lastowska, M., Al-Afghani, H., Al-Balool, H., Sheth, H., Mercer, E., Coxhead, J., . . . Jackson, M. (2013). Identification of a neuronal transcription factor network involved in medulloblastoma development. Acta neuropathologica communications, 1(1), 35-1-35-16.
    DOI Scopus27 WoS29 Europe PMC24
    2013 Burt, A. (2013). Roger Cotton Histopathology Prize 2012. Histopathology, 62(7), 975.
    DOI
    2012 Elsharkawy, A., McPherson, S., Masson, S., Burt, A., Dawson, R., & Hudson, M. (2012). Cholestase bei jungen Mannern nach Anabolika-Einnahme [Cholestasis secondary to anabolic steroid use in young men]. Praxis, 101(10), 661-664.
    DOI
    2012 Burt, A. (2012). Editorial. Histopathology, 60(6), 853.
    DOI
    2012 Burt, A. (2012). Roger Cotton Histopathology prize 2011. Histopathology, 61(5), 759.
    DOI
    2012 Mathurin, P., Hadengue, A., Bataller, R., Addolorato, G., Burra, P., Burt, A., . . . Nevens, F. (2012). EASL clinical practical guidelines: management of alcoholic liver disease. Journal of Hepatology, 57(2), 399-420.
    DOI Scopus417 WoS364 Europe PMC263
    2012 Burt, A. (2012). Changing of the guard. Histopathology, 60(2), 233-235.
    DOI Scopus2 WoS2
    2012 Simeon-Dubach, D., Burt, A., & Hall, P. (2012). Quality really matters: The need to improve specimen quality in biomedical research. Journal of Pathology, 228(4), 431-433.
    DOI Scopus32 WoS30 Europe PMC19
    2012 Zeybel, M., Hardy, T., Wong, Y., Mathers, J., Fox, C., Gackowska, A., . . . Mann, J. (2012). Erratum: Multigenerational epigenetic adaptation of the hepatic woundhealing response (Nature Medicine (2012) 18 (1369-1377)). Nature Medicine, 18(10), 1592.
    DOI Scopus6 WoS5
    2012 Tunwar, S., Trembling, P., Guha, I., Parkes, J., Kaye, P., Burt, A., . . . Rosenberg, W. (2012). Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatology, 57(1), 103-111.
    DOI Scopus53 WoS59 Europe PMC36
    2012 Robinson, S., Wilson, C., Burt, A., Manas, D., & White, S. (2012). Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Annals of Surgical Oncology, 19(13), 4287-4299.
    DOI Scopus88 WoS81 Europe PMC53
    2012 Zeybel, M., Hardy, T., Wong, Y., Mathers, J., Fox, C., Gackowska, A., . . . Mann, J. (2012). Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nature Medicine, 18(9), 1369-1377.
    DOI Scopus153 WoS138 Europe PMC118
    2012 Bechmann, L., Gastaldelli, A., Vetter, D., Patman, G., Pascoe, L., Hannivoort, R., . . . Reeves, H. (2012). Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology, 55(4), 1083-1093.
    DOI Scopus35 WoS31 Europe PMC25
    2012 Simeon-Dubach, D., Burt, A., & Hall, P. (2012). Quality really matters: the need to improve specimen quality in biomedical research. Histopathology, 61(6), 1003-1005.
    DOI Scopus13 WoS11 Europe PMC9
    2012 Perugorria, M., Wilson, C., Zeybel, M., Walsh, M., Amin, S., Robinson, S., . . . Mann, J. (2012). Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation. Hepatology, 56(3), 1129-1139.
    DOI Scopus72 WoS64 Europe PMC50
    2012 Kelly, P., Spence, R., Dasari, B., Burt, A., Taylor, M., & Loughrey, M. (2012). Primary hepatocellular carcinoma of the pancreas: a case report and review of the heterogeneous group of pancreatic hepatoid carcinomas. Histopathology, 60(6), 1012-1015.
    DOI Scopus12 WoS13 Europe PMC12
    2012 Elsharkawy, A., McPherson, S., Masson, S., Burt, A., Dawson, R., & Hudson, M. (2012). Cholestasis secondary to anabolic steroid use in young men. BMJ, 344(7843), e468-1-e468-3.
    DOI Scopus19 WoS12 Europe PMC8
    2011 de Alwis, N., Aithal, G., Bugianesi, E., Leathart, J., Hudson, G., Pyle, A., . . . Day, C. (2011). Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease. Mitochondrion, 11(1), 234-235.
    DOI Scopus4 WoS4 Europe PMC2
    2011 Ebrahimkhani, M., Oakley, F., Murphy, L., Mann, J., Moles, A., Perugorria, M., . . . Mann, D. (2011). Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nature Medicine, 17(12), 1668-1673.
    DOI Scopus107 WoS100 Europe PMC73
    2011 Chan, A., & Burt, A. (2011). Liver cell dysplasia and early hepatocellular carcinoma. Diagnostic Histopathology, 17(12), 512-520.
    DOI Scopus1
    2011 Griffin, S., Burt, A., & Jennings, N. (2011). Lymph node metastasis in early esophageal adenocarcinoma. Annals of Surgery, 254(5), 731-737.
    DOI Scopus39 WoS37 Europe PMC26
    2010 Van Der Laan, L., Hudson, M., McPherson, S., Zondervan, P., Thomas, R., Kwekkeboom, J., . . . Metselaar, H. (2010). Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus. Transplantation Proceedings, 42(10), 4573-4577.
    DOI Scopus7 WoS8 Europe PMC6
    2010 Rygiel, K., Robertson, H., Willet, J., Brain, J., Burt, A., Jones, D., & Kirby, J. (2010). T Cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection. Liver Transplantation, 16(5), 567-576.
    DOI Scopus10 WoS8 Europe PMC6
    2010 McPherson, S., Stewart, S., Henderson, E., Burt, A., & Day, C. (2010). Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut, 59(9), 1265-1269.
    DOI Scopus312 WoS289 Europe PMC207
    2010 Harte, A., da Silva, N., Creely, S., McGee, K., Billyard, T., Youssef-Elabd, E., . . . McTernan, P. (2010). Elevated endotoxin levels in non-alcoholic fatty liver disease. Journal of Inflammation, 7(15), 1-10.
    DOI Scopus185 WoS168 Europe PMC116
    2010 Parkes, J., Roderick, P., Harris, S., Day, C., Mutimer, D., Collier, J., . . . Rosenberg, W. (2010). Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut, 59(9), 1245-1251.
    DOI Scopus178 WoS166 Europe PMC119
    2010 Dongiovanni, P., Valenti, L., Rametta, R., Daly, A., Nobili, V., Mozzi, E., . . . Fargion, S. (2010). Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut, 59(2), 267-273.
    DOI Scopus83 WoS79 Europe PMC58
    2010 Brain, J., & Burt, A. (2010). Abrikosoff's tumor and the hepatobiliary system: A curiosa revisited. Gastroenterology and Hepatology, 6(5), 337-338.
    2010 Wallace, K., Flecknell, P., Burt, A., & Wright, M. (2010). Disrupted pancreatic exocrine differentiation and malabsorption in response to chronic elevated systemic glucocorticoid. American Journal of Pathology, 177(3), 1225-1232.
    DOI Scopus15 WoS12 Europe PMC7
    2010 Gieling, R., Elsharkawy, A., Caamano, J., Cowie, D., Wright, M., Ebrahimkhani, M., . . . Mann, D. (2010). The c-Rel subunit of nuclear factor-κB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation. Hepatology, 51(3), 922-931.
    DOI Scopus36 WoS33 Europe PMC25
    2009 De Alwis, N., Hudson, G., Burt, A., Day, C., & Chinnery, P. (2009). Human liver stem cells originate from the canals of hering. Hepatology, 50(3), 992-993.
    DOI Scopus13 WoS13 Europe PMC12
    2009 Burt, A. (2009). Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology, 49(2), 658-664.
    DOI Scopus467 WoS403 Europe PMC304
    2009 Frith, J., Day, C., Henderson, E., Burt, A., & Newton, J. (2009). Non-alcoholic fatty liver disease in older people. Gerontology, 55(6), 607-613.
    DOI Scopus97 WoS91 Europe PMC63
    2008 Duconge, J., Merino, N., Alvarez, D., Beausoleil, I., Fernandez-Sanchez, E., Rodriguez, L., & Burt, A. (2008). Kinetics of monoclonal anti-epidermal growth factor receptor antibody (IOR EGF/R3)-induced apoptosis in human carcinoma bearing nude mice. Puerto Rico Health Sciences Journal, 27(1), 35-41.
    2008 Gennery, A., Slatter, M., Rice, J., Hoefsloot, L., Barge, D., McLean-Tooke, A., . . . Johnson, D. (2008). Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clinical and Experimental Immunology, 153(1), 75-80.
    DOI Scopus61 WoS52 Europe PMC43
    2008 Rygiel, K., Robertson, H., Marshall, H., Pekalski, M., Zhao, L., Booth, T., . . . Kirby, J. (2008). Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Laboratory Investigation, 88(2), 112-123.
    DOI Scopus182 WoS168 Europe PMC126
    2008 Wallace, K., Burt, A., & Wright, M. (2008). Liver fibrosis. Biochemical Journal, 411(1), 1-18.
    DOI Scopus229 WoS207 Europe PMC154
    2008 Guha, I., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., . . . Rosenberg, W. (2008). Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology, 47(2), 455-460.
    DOI Scopus414 WoS378 Europe PMC271
    2008 Gieling, R., Burt, A., & Mann, D. (2008). Fibrosis and cirrhosis reversibility - molecular mechanisms. Clinics in Liver Disease, 12(4), 915-937.
    DOI Scopus71 WoS62 Europe PMC45
    2008 Newton, J., Jones, D., Henderson, E., Kane, L., Wilton, K., Burt, A., & Day, C. (2008). Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease. Gut, 57(6), 807-813.
    DOI Scopus115 WoS107 Europe PMC69
    2008 Tiniakos, D., Mathew, J., Kittas, C., & Burt, A. (2008). Ontogeny of human intrahepatic innervation. Virchows Archiv-An International Journal of Pathology, 452(4), 435-442.
    DOI Scopus7 WoS7 Europe PMC6
    2008 Jones, D., Palmer, J., Burt, A., & Kirby, J. (2008). The specificity of liver inflammation in mouse models of primary biliary cirrhosis. Hepatology, 48(4), 1353-1354.
    DOI Scopus1 Europe PMC1
    2008 Kirby, J., Robertson, H., Marshall, H., Rygiel, K., Hudson, M., Jones, D., & Burt, A. (2008). Epithelial to mesenchymal transition in primary sclerosing cholangitis. Liver International, 28(8), 1176-1177.
    DOI Scopus6 WoS5 Europe PMC3
    2008 Hedge, M. M., Thompson, N. P., Burt, A. D., Day, C. P., & Reeves, H. (2008). Warfarin induced cholestatic jaundice in a patient receiving total parenteral nutrition. CME Gastroenterology, Hepatology & Nutrition, 9(1), 27-29.
    2007 Haugk, B., El-Refaie, A., & Burt, A. (2007). Pathology of liver transplantation. Current Diagnostic Pathology, 13(1), 75-84.
    DOI Scopus2
    2007 Wilson, C. H., Agarwal, K., Carter, V., Burt, A. D., Hubscher, S., Talbot, D., . . . Manas, D. M. (2007). Late humoral rejection in a compliant ABO-compatible liver transplant recipient (vol 82, pg 988, 2006). TRANSPLANTATION, 83(1), 70.
    2007 Prabhu, V., & Burt, A. (2007). Pathology of liver tumours. Surgery, 25(1), 10-15.
    DOI Scopus3
    2007 Angulo, P., Hui, J., Marchesini, G., Bugianesi, E., George, J., Farrell, G., . . . Day, C. (2007). The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 45(4), 846-854.
    DOI Scopus1068 WoS1004 Europe PMC722
    2007 Robertson, H., Kirby, J., Yip, W., Jones, D., & Burt, A. (2007). Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology, 45(4), 977-981.
    DOI Scopus120 WoS107 Europe PMC87
    2007 Zhao, L., & Burt, A. (2007). The diffuse stellate cell system. Journal of Molecular Histology, 38(1), 53-64.
    DOI Scopus64 WoS56 Europe PMC42
    2007 Wilson, C., Agarwal, K., Carter, V., Burt, A., Hübscher, S., Talbot, D., . . . Manas, D. (2007). Erratum: Late humoral rejection in a compliant ABO-compatible liver transplant recipient (Transplantation (2006) 82, (988)). Transplantation, 83(1), 70.
    DOI
    2006 Wilson, C., Agarwal, K., Talbot, D., Jaques, B., Manas, D., Carter, V., . . . Hübscher, S. (2006). Late humoral rejection in a compliant ABO-compatible liver transplant recipient [4]. Transplantation, 82(7), 988-989.
    DOI Scopus31 WoS29 Europe PMC21
    2006 Benitez-Rajal, J., Lorite, M., Burt, A., Day, C., & Thompson, M. (2006). Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: Effects of platelet-derived growth factor and extracellular nucleotides. American Journal of Physiology - Gastrointestinal and Liver Physiology, 291(5), G977-G986.
    DOI Scopus10 WoS11 Europe PMC7
    2006 Mathew, J., Igbokwe, U., Morley, N., & Burt, A. (2006). Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous α<inf>1</inf>-antitrypsin deficiency. Dermatology, 213(2), 147-149.
    DOI
    2006 Tyler, J., Robertson, H., Booth, T., Burt, A., & Kirby, J. (2006). Chronic allograft nephropathy: Intraepithelial signals generated by transforming growth factor-β and bone morphogenetic protein-7. American Journal of Transplantation, 6(6), 1367-1376.
    DOI Scopus37 WoS36 Europe PMC27
    2006 Nielsen, S., Bassendine, M., Burt, A., Martin, C., Pumeechockchai, W., & Toms, G. (2006). Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. Journal of Virology, 80(5), 2418-2428.
    DOI Scopus267 WoS255 Europe PMC205
    2006 Price, D., Bassendine, M., Norris, S., Golding, C., Toms, G., Schmid, M., . . . Donaldson, P. (2006). Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection. Gut, 55(5), 715-718.
    DOI Scopus70 WoS61 Europe PMC51
    2006 Yip, W., & Burt, A. (2006). Alcoholic liver disease. Seminars in Diagnostic Pathology, 23(3-4), 149-160.
    DOI Scopus103 WoS87 Europe PMC58
    2006 Fenwick, F., Bassendine, M., Agarwal, K., Bevitt, D., Pumeechockchai, W., Burt, A., & Toms, G. (2006). Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation. Journal of Clinical Pathology, 59(2), 174-178.
    DOI Scopus16 WoS13 Europe PMC11
    2005 Ahmed El-Refaie, A., & Burt, A. (2005). Mast cells and c-Kit expression in liver allograft rejection. Histopathology, 47(4), 375-381.
    DOI Scopus15 WoS12 Europe PMC6
    2005 Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., . . . Day, C. (2005). Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut, 54(7), 987-993.
    DOI Scopus139 WoS130 Europe PMC85
    2005 Lamb, P., Griffin, S., Burt, A., Lloyd, J., Karat, D., & Hayes, N. (2005). Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. British Journal of Surgery, 92(1), 60-67.
    DOI Scopus64 WoS56 Europe PMC52
    2005 Mathew, J., Leong, M., Morley, N., & Burt, A. (2005). A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis. BMC Dermatology, 5(1), 12.
    DOI Scopus2 Europe PMC1
    2005 Rai, R., Richardson, C., Flecknell, P., Robertson, H., Burt, A., & Manas, D. (2005). Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). Journal of Surgical Research, 129(1), 147-151.
    DOI Scopus55 Europe PMC30
    2005 Rostron, A., Carter, V., Mutunga, M., Cavanagh, G., O'Suilleabhain, C., Burt, A., . . . Manas, D. (2005). A case of acute humoral rejection in liver transplantation: Successful treatment with plasmapheresis and mycophenolate mofetil. Transplant International, 18(11), 1298-1301.
    DOI Scopus27 WoS25 Europe PMC18
    2004 Rosenberg, W., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D., . . . Arthur, M. (2004). Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology, 127(6), 1704-1713.
    DOI Scopus727 WoS637 Europe PMC478
    2004 Palmer, J., Robe, A., Burt, A., Kirby, J., & Jones, D. (2004). Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology, 39(6), 1583-1592.
    DOI Scopus23 WoS21 Europe PMC15
    2004 Nielsen, S., Bassendine, M., Burt, A., Bevitt, D., & Toms, G. (2004). Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. Journal of General Virology, 85(6), 1497-1507.
    DOI Scopus49 WoS52 Europe PMC37
    2004 Aithal, G., Haugk, B., Das, S., Card, T., Burt, A., & Record, C. (2004). Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified?. Alimentary Pharmacology and Therapeutics, 19(4), 391-399.
    DOI Scopus96 WoS79 Europe PMC53
    2004 Robertson, H., Ali, S., McDonnell, B., Burt, A., & Kirby, J. (2004). Chronic Renal Allograft Dysfunction: The Role of T Cell-Mediated Tubular Epithelial to Mesenchymal Cell Transition. Journal of the American Society of Nephrology, 15(2), 390-397.
    DOI Scopus95 WoS86 Europe PMC76
    2003 Roskams, T., Baptista, A., Bianchi, L., Burt, A., Callea, F., Denk, H., . . . Thaler, H. (2003). Histopathology of portal hypertension: A practical guideline. Histopathology, 42(1), 2-13.
    DOI Scopus46 WoS35 Europe PMC27
    2002 Jones, D., Palmer, J., Burt, A., Walker, C., Robe, A., & Kirby, J. (2002). Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology, 36(3), 679-686.
    DOI Scopus39 WoS37 Europe PMC29
    2002 Burt, A. (2002). Primary biliary cirrhosis and other ductopenic diseases. Clinics in Liver Disease, 6(2), 363-380.
    DOI Scopus24 Europe PMC9
    2002 Agarwal, K., Jones, D., Watt, F., Burt, A., Floreani, A., & Bassendine, M. (2002). Familial primary biliary cirrhosis and autoimmune cholangitis. Digestive and Liver Disease, 34(1), 50-52.
    DOI Scopus4 WoS3 Europe PMC1
    2002 Agarwal, K., Jones, D., Burt, A., Hudson, M., & James, O. (2002). Metastatic breast carcinoma presenting as acute liver failure and portal hypertension. American Journal of Gastroenterology, 97(3), 750-751.
    DOI Scopus17 WoS12 Europe PMC12
    2002 Jones, D., Palmer, J., Bennett, K., Robe, A., Yeaman, S., Robertson, H., . . . Kirby, J. (2002). Investigation of a mechanism for accelerated breakdown of immune tolerance to the primary biliary cirrhosis-associated autoantigen, pyruvate dehydrogenase complex. Laboratory Investigation, 82(2), 211-219.
    DOI Scopus24 WoS24 Europe PMC18
    2002 Prince, M., Burt, A., & Jones, D. (2002). Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut, 50(3), 436-439.
    DOI Scopus138 WoS113 Europe PMC83
    2002 Lamb, P., Dresner, S., Lloyd, J., O'Driscoll, K., Burt, A., Karat, D., . . . Griffin, S. (2002). The sentinel node concept in the metastatic dissemination of oesophageal adenocarcinoma. BRITISH JOURNAL OF SURGERY, 89, 37.
    2001 Burt, A. (2001). Steatosis and steatohepatitis. Current Diagnostic Pathology, 7(2), 141-147.
    DOI Scopus8
    2001 Benitez, J., Lorite, M., Burt, A., Day, C., & Geerts, A. (2001). Identification of phospholipase D gene products in activated rat hepatic stellate cells - Stimulation by PDGF and nucleotides. JOURNAL OF HEPATOLOGY, 34, 90.
    2001 Reeves, H., Burt, A., & Day, C. (2001). Integrin receptor expression changes in diseased hepatic stellate cells. GUT, 48, A108-A109.
    2001 Aithal, G., Haugk, B., Gumustop, B., Burt, A., & Record, C. (2001). Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified?.. HEPATOLOGY, 34(4), 342A.
    2001 Mohamed, M., Burt, A., Robertson, H., Kirby, J., & Talbot, D. (2001). TGF-beta expression in protocol transplant liver biopsies: A comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1378-1380.
    DOI WoS5 Europe PMC6
    2001 Robertson, H., Wong, W., Burt, A., Mohamed, M., Talbot, D., & Kirby, J. (2001). Relationship between TGF beta(1), intratubular CD103 positive T cells and acute renal allograft rejection. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1159.
    DOI WoS6 Europe PMC3
    2001 Jowett, S., Agarwal, K., Smith, B., Craig, W., Hewett, M., Bassendine, D., . . . Bassendine, M. (2001). Managing chronic hepatitis C acquired through intravenous drug use. QJM - Monthly Journal of the Association of Physicians, 94(3), 153-158.
    DOI Scopus56 WoS44 Europe PMC28
    2001 Robertson, H., Keong Wong, W., Talbot, D., Burt, A., & Kirby, J. (2001). Tubulitis after renal transplantation: Demonstration of an association between CD103+ T cells, transforming growth factor β<inf>1</inf>expression and rejection grade. Transplantation, 71(2), 306-313.
    DOI Scopus57 WoS53 Europe PMC37
    2001 Koeppen, H., Wright, B., Burt, A., Quirke, P., McNicol, A., Dybdal, N., . . . Hillan, K. (2001). Overexpression of HER2/neu in solid tumours: An immunohistochemical survey. Histopathology, 38(2), 96-104.
    DOI Scopus129 WoS119 Europe PMC81
    2001 Burt, A. (2001). Autoimmune liver disease. CPD Bulletin Cellular Pathology, 3(2), 64-67.
    2001 Drasar, P. (2001). Editorial. CHEMICKE LISTY, 95(4), 193.
    2000 Reynaert, H., Burt, A., & Geerts, A. (2000). Prions in activated hepatic stellate cells: Not a surprise after all. Journal of Hepatology, 33(5), 838-841.
    DOI Scopus4 WoS4 Europe PMC3
    2000 Jones, D., Palmer, J., Kirby, J., De Cruz, D., McCaughan, G., Sedgwick, J., . . . Bassendine, M. (2000). Experimental autoimmune cholangitis: A mouse model of immune-mediated cholangiopathy. Liver, 20(5), 351-356.
    DOI Scopus32 WoS28 Europe PMC18
    2000 Reeves, H., Dack, C., Peak, M., Burt, A., & Day, C. (2000). Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. Journal of Hepatology, 32(3), 465-472.
    DOI Scopus63 WoS58 Europe PMC36
    2000 Newton, J., Jones, D., Metcalf, J., Park, J., Burt, A., Bassendine, M., & James, O. (2000). Presentation and mortality of primary biliary cirrhosis in older patients. Age and Ageing, 29(4), 305-309.
    DOI Scopus25 WoS15 Europe PMC15
    2000 Reeves, H., Thompson, M., Dack, C., Burt, A., & Day, C. (2000). The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cells. Hepatology, 31(1), 95-100.
    DOI Scopus25 WoS23 Europe PMC14
    2000 Bennett, K., Robertson, H., Bone, M., Burt, A., Kirby, J., & Jones, D. (2000). Immunohistochemical analaysis of portal tract changes in experimental autoimmune cholangitis, a murine model of non-suppurative destructive cholangitis (NSDC).. HEPATOLOGY, 32(4), 171A.
    2000 Allen, M. (2000). Editorial. Outskirts, 7(4), 270.
    DOI
    2000 Eza, D., Burr, A., O'Toole, K., & Burt, A. (2000). Inhibition of non-parenchymal cell responses to acute liver injury using neutralising anti-growth factor antibodies. JOURNAL OF PATHOLOGY, 190, 12A.
    2000 Lorite, M., Benitez, J., Burt, A., Day, C., & Thompson, M. (2000). Nucleotides stimulate protein synthesis in hepatic stellate cells: Potential role of phospholipase D - Mediated lipid hydrolysis.. JOURNAL OF PATHOLOGY, 190, 4A.
    2000 Burt, A., Jones, D., Palmer, J., Kirby, J., DeCruz, D., McCaughan, G., . . . Bassendine, M. (2000). Histopathology of experimental autoimmune cholangitis - a mouse model of primary biliary cirrhosis. JOURNAL OF PATHOLOGY, 190, 3A.
    2000 Burt, A. (2000). Viral hepatitis in Western Europe. JOURNAL OF PATHOLOGY, 190, 28A.
    2000 Bone, M., Jones, D., Kirby, J., Robertson, H., Burt, A., Jawahari, A., & Hudson, M. (2000). Ulcerative colitis: An investigation of the potential role played by a B-E(7) +VE T-cells.. GASTROENTEROLOGY, 118(4), A1334.
    DOI
    1999 Fenwick, F., Bevitt, D., Burt, A., Pumeechockchai, W., Bassendine, M., & Toms, G. (1999). Detection of hepatitis C virus structural and nonstructural proteins by immunohistochemistry.. HEPATOLOGY, 30(4), 208A.
    1999 Smith, B., Grove, J., Burt, A., & Bassendine, M. (1999). No evidence for involvement of interleukin-10 (IL-10) promoter gene polymorphisms in infuencing outcome of hepatitis C virus infection. HEPATOLOGY, 30(4), 590A.
    1999 Reeves, H., Thompson, M., Burt, A., & Day, C. (1999). Signal cascade cross-talk in PDGF-induced HSC proliferation. GUT, 44, A97.
    1999 Jones, D., Palmer, J., Yeaman, S., Kirby, J., Bassendine, M., & Burt, A. (1999). The time-course of bile duct lesion development in experimental autoimmune cholangitis (a mouse model of primary biliary cirrhosis-PBC).. HEPATOLOGY, 30(4), 564A.
    1999 Case, M., Burt, A., Hughes, J., Palmer, J., Collier, J., Bassendine, M., . . . Major, G. (1999). Erratum: Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol (Journal of Immunological Methods (1999) 223 (93-106)). Journal of Immunological Methods, 226(1-2), 189-190.
    DOI
    1999 Jones, D., Palmer, J., Yeaman, S., Kirby, J., Bassendine, M., & Burt, A. (1999). The time-course of bile duct lesion development in experimental autoimmune cholangitis (A mouse model of primary biliary cirrhosis -PBC).. HEPATOLOGY, 30(4), 318A.
    WoS2
    1999 Case, M., Burt, A., Hughes, J., Palmer, J., Collier, J., Bassendine, M., . . . Major, G. (1999). Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol (vol 223, pg 93, 1999). JOURNAL OF IMMUNOLOGICAL METHODS, 226(1-2), 189-190.
    1999 Wright, C., Strauss, S., Toole, K., Burt, A., & Robson, S. (1999). Composition of the pulmonary interstitium during normal development of the human fetus. Pediatric and Developmental Pathology, 2(5), 424-431.
    DOI Scopus16 WoS14 Europe PMC12
    1999 Burt, A. (1999). Pathobiology of hepatic stellate cells. Journal of Gastroenterology, 34(3), 299-304.
    DOI Scopus41 WoS36 Europe PMC25
    1999 James, O., Bhopal, R., Howel, D., Gray, J., Burt, A., & Metcalf, J. (1999). Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology, 30(2), 390-394.
    DOI Scopus181 WoS168 Europe PMC128
    1999 Jones, D., James, O., Portmann, B., Burt, A., Williams, R., & Hudson, M. (1999). Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology, 30(1), 53-57.
    DOI Scopus88 WoS74 Europe PMC52
    1999 Case, M., Burt, A., Hughes, J., Palmer, J., Collier, J., Bassendine, M., . . . Major, G. (1999). Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol. Journal of Immunological Methods, 223(1), 93-106.
    DOI Scopus16 WoS12 Europe PMC7
    1999 Lorite, M., Benitez, J., Bleazard, L., Burt, A., Day, C., & Thompson, M. (1999). Stimulation of protein and DNA synthesis by ATP in hepatic stellate cells: Potential role of phospholipase D-mediated lipid hydrolysis.. HEPATOLOGY, 30(4), 487A.
    1998 Burr, A., Toole, K., Chapman, C., Hines, J., & Burt, A. (1998). Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. Journal of Pathology, 185(3), 298-302.
    DOI Scopus56 WoS52 Europe PMC33
    1998 Green, S., Chapman, P., Burn, J., Burt, A., Bennett, M., Appleton, D., . . . Mathers, J. (1998). Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer. Gut, 43(1), 85-92.
    DOI Scopus14 WoS15 Europe PMC21
    1998 Olivieri, N., Brittenham, G., Mclaren, C., Templeton, D., Cameron, R., Mcclelland, R., . . . Fleming, K. (1998). Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. New England Journal of Medicine, 339(7), 417-423.
    DOI Scopus331 WoS297 Europe PMC187
    1998 Smith, B., Grove, J., Guzail, M., Day, C., Daly, A., Burt, A., & Bassendine, M. (1998). Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology, 27(6), 1695-1699.
    DOI Scopus205 WoS183 Europe PMC124
    1998 Karayiannis, P., Brind, A., Pickering, J., Mathew, J., Burt, A., Hess, G., . . . Thomas, H. (1998). Hepatitis G virus does not cause significant liver disease after liver transplantation. Journal of Viral Hepatitis, 5(1), 35-42.
    DOI Scopus9 WoS7 Europe PMC5
    1998 Johnson, S., Burr, A., Toole, K., Dack, C., Mathew, J., & Burt, A. (1998). Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis. Journal of Gastroenterology and Hepatology (Australia), 13(2), 145-151.
    DOI Scopus16 WoS19 Europe PMC10
    1998 Grove, J., Daly, A., Burt, A., Guzail, M., James, O., Bassendine, M., & Day, C. (1998). Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut, 43(2), 262-266.
    DOI Scopus86 WoS70 Europe PMC40
    1998 Smith, B., Grove, J., Day, C., Daly, A., Burt, A., & Bassendine, M. (1998). Heterozygosity for haemochromatosis is associated with more fibrosis in chronic hepatitis C. GUT, 43(1), 154.
    1998 Reeves, H., Peak, M., Burt, A., & Day, C. (1998). The antifibrogenic effect of interferon-alpha is via inhibition of p38 map kinase activity. GUT, 43(1), 152.
    1998 Burt, A., Mutton, A., & Day, C. (1998). Diagnosis and interpretation of steatosis and steatohepatitis. Seminars in Diagnostic Pathology, 15(4), 246-258.
    Scopus236 WoS205 Europe PMC126
    1998 Reeves, H., Peak, M., Burt, A., & Day, C. (1998). Stress-activated protein kinases (SAPKs) are involved in the activation of hepatic stellate cells. GUT, 43(1), 151.
    1998 Thompson, M., Dack, C., Reeves, H., Burt, A., & Day, C. (1998). PDGF but not TGF alpha activates phospholipase C and phospholipase D mediated lipid hydrolysis in hepatic stellate cells.. HEPATOLOGY, 28(4), 299A.
    WoS1
    1998 Newton, J., Jones, D., Metcalf, J., Burt, A., Bassendine, M., & James, O. (1998). The presentation of Primary Biliary Cirrhosis in the elderly.. GASTROENTEROLOGY, 114(4), A1311.
    DOI WoS1
    1998 Burt, A. (1998). Untitled. LIVER, 18(1), 1.
    1998 Grove, J., Daly, A., Burt, A., Guzail, M., Bassendine, M., & Day, C. (1998). Do HLA-H mutations influence liver iron content or disease risk in alcoholics?. GUT, 43(1), 153-154.
    1998 Newton, J., Jones, D., Metcalf, J., Burt, A., Bassendine, M., & James, O. (1998). Primary biliary cirrhosis in the elderly: Increased liver related mortality despite similar clinical features at presentation.. HEPATOLOGY, 28(4), 540A.
    1997 Park, J., Hudson, M., Gray, S., & Burt, A. (1997). Abnormalities of portal tract vasculature in primary biliary cirrhosis. JOURNAL OF PATHOLOGY, 181, A49.
    1997 Smith, B., Chapman, C., Burt, A., Toms, G., & Bassendine, M. (1997). Post-transfusion hepatitis C: Variable outcome in a cohort of donor-recipient pairs. GUT, 41, A129.
    1997 Grove, J., Daly, A., Burt, A., Guzail, M., Bassendine, M., & Day, C. (1997). HLA-H mutations, hepatic iron content and risk of advanced liver disease in alcoholics.. HEPATOLOGY, 26(4), 585.
    1997 Smith, B., Grove, J., Day, C., Daly, A., Burt, A., & Bassendine, M. (1997). Heterozygosity for haemochromatosis is associated with more fibrosis in chronic hepatitis C.. HEPATOLOGY, 26(4), 1899.
    1997 Chapman, C., Mathew, J., Milton, I., Piggott, N., Steward, M., & Burt, A. (1997). Distribution of c-met protein in normal human liver and following acute and chronic liver injury. JOURNAL OF PATHOLOGY, 181, A10.
    1997 Reeves, H., Peak, M., Burt, A., & Day, C. (1997). The role of stress-activated protein kinases in the activation of hepatic stellate cells.. HEPATOLOGY, 26(4), 1277.
    WoS1
    1997 Reeves, H., Peak, M., Burt, A., & Day, C. (1997). Interferon alpha inhibits p38 MAP kinase activity in hepatic stellate cells.. HEPATOLOGY, 26(4), 1276.
    WoS1
    1997 Newton, J., Burt, A., Park, J., Mathew, J., Bassendine, M., & James, O. (1997). Autoimmune hepatitis in older patients. Age and Ageing, 26(6), 441-444.
    DOI Scopus52 WoS41 Europe PMC26
    1997 Smith, B., Chapman, C., Burt, A., Toms, G., & Bassendine, M. (1997). Outcome of post-transfusion hepatitis C: Disease severity in blood-component recipients and their implicated donors. QJM - Monthly Journal of the Association of Physicians, 90(9), 587-592.
    DOI Scopus12 WoS11 Europe PMC8
    1997 Case, M., Major, G., Bassendine, M., & Burt, A. (1997). The universality of immuno-PCR for ultrasensitive antigen detection. BIOCHEMICAL SOCIETY TRANSACTIONS, 25(2), S374.
    DOI WoS13 Europe PMC6
    1997 Wright, C., Burt, A., Strauss, S., Toole, K., & Robson, S. (1997). Cell proliferation in early human lung development.. JOURNAL OF PATHOLOGY, 182, A49.
    1996 Brind, A., Watson, J., Burt, A., Kestevan, P., Wallis, J., Proctor, S., & Bassendine, M. (1996). Non-Hodgkin's lymphoma and hepatitis C virus infection. Leukemia and Lymphoma, 21(1-2), 127-130.
    DOI Scopus63 WoS63 Europe PMC39
    1996 Ball, S., Davison, J., Burt, A., McNicol, A., & Baylis, P. (1996). Cushing's syndrome secondary to ectopic ACTH secretion from a primary ovarian carcinoma. Clinical Endocrinology, 45(6), 775-778.
    DOI Scopus13 WoS14 Europe PMC9
    1996 Reeves, H., Burt, A., Wood, S., & Day, C. (1996). Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. Journal of Hepatology, 25(5), 677-683.
    DOI Scopus126 WoS113 Europe PMC88
    1996 Morris, A., Singh-Kler, R., Perry, R., Griffiths, P., Burt, A., Chee, P. W., . . . Turnbull, D. (1996). Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease. Journal of Child Neurology, 11(5), 417-419.
    DOI Scopus12 WoS11 Europe PMC5
    1996 Burr, A., Toole, K., Mathew, J., Hines, J., Chapman, C., & Burt, A. (1996). Transforming growth factor-α expression is altered during experimental hepatocarcinogenesis. Journal of Pathology, 179(3), 276-282.
    DOI Scopus21 WoS21 Europe PMC14
    1996 Hinchliffe, S., Woods, S., Gray, S., & Burt, A. (1996). Cellular distribution of androgen receptors in the liver. Journal of Clinical Pathology, 49(5), 418-420.
    DOI Scopus5 WoS7 Europe PMC4
    1996 Watson, J., Brind, A., Chapman, C., Bates, C., Gould, F., Johnson, S., . . . Bassendine, M. (1996). Hepatitis C virus: Epidemiology and genotypes in the north east of England. Gut, 38(2), 269-276.
    DOI Scopus65 WoS58 Europe PMC43
    1996 Leon, M., Bassendine, M., Gibbs, P., Burt, A., Thick, M., & Kirby, J. (1996). Hepatic allograft rejection: Regulation of the immunogenicity of human intrahepatic biliary epithelial cells. Liver Transplantation and Surgery, 2(1), 37-45.
    DOI Scopus11 Europe PMC6
    1996 Mathew, J., Geerts, A., & Burt, A. (1996). Pathobiology of hepatic stellate cells. Hepato-Gastroenterology, 43(7), 72-91.
    Scopus36 WoS33 Europe PMC25
    1996 Burt, A. (1996). Special topic - Hepatic inflammation and fibrogenesis. Hepato-Gastroenterology, 43(7), 2-3.
    1996 Goldin, R., Goldin, J., Burt, A., Dhillon, P., Hubscher, S., Wyatt, J., & Patel, N. (1996). Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. Journal of Hepatology, 25(5), 649-654.
    DOI Scopus127 WoS118 Europe PMC90
    1996 Burr, A., Hillan, K., McLaughlin, K., Ferrier, R., Chapman, C., Mathew, J., & Burt, A. (1996). Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis. Hepatology, 24(5), 1282-1287.
    DOI Scopus22 WoS20 Europe PMC7
    1996 Newton, J., Burt, A., Park, J., Mathew, J., Bassendine, M., & James, O. (1996). Is the new international diagnostic scoring system for autoimmune hepatitis too rigid?. HEPATOLOGY, 24(4), 434.
    1996 Case, M., Major, G., Bassendine, M., & Burt, A. (1996). The universality of immuno-PCR for ultrasensitive antigen detection. IMMUNOLOGY, 89, OH394.
    1996 Mathew, J., Mines, J., Obafunwa, J., Burr, A., Toole, K., & Burt, A. (1996). CD44 is expressed in hepatocellular carcinomas showing vascular invasion. Journal of Pathology, 179(1), 74-79.
    DOI Scopus63 WoS41 Europe PMC33
    1996 Tiniakos, D., Lee, J., & Burt, A. (1996). Innervation of the liver: Morphology and function. Liver, 16(3), 151-160.
    DOI Scopus43 WoS37 Europe PMC24
    1996 Collier, J., Bassendine, M., Burt, A., & Major, G. (1996). Characterisation of the DNA repair enzyme for O<sup>6</sup>-methylguanine in cirrhosis. Journal of Hepatology, 25(2), 158-165.
    DOI Scopus15 WoS13 Europe PMC6
    1996 Anderson, J., Birch, P., McIntosh, G., Parr, A., Burt, A., Lennard, T., . . . Angus, B. (1996). Over expression of CD44 variants acts as a useful secondary indicator of prognosis in patients with carcinomas of the breast. JOURNAL OF PATHOLOGY, 179, A19.
    1996 Burt, A. (1996). Hepatic inflammation and fibrogenesis. HEPATO-GASTROENTEROLOGY, 43(7), 1.
    1996 Reeves, H., Burt, A., & Day, C. (1996). The antiproliferative effect of IFN alpha correlates with inhibition of MAP kinase activation. HEPATOLOGY, 23(1), T53.
    1995 BURR, A., TOOLE, K., HINES, J., CHAPMAN, C., & BURT, A. (1995). ANTI-HEPATOCYTE GROWTH-FACTOR ANTIBODY INHIBITS THE IN-VIVO PROLIFERATIVE RESPONSE OF HEPATOCYTES TO ACUTE LIVER-INJURY. GASTROENTEROLOGY, 108(4), A1041.
    DOI
    1995 Farrell, D., Hines, J., Walls, A., Kelly, P., Bennett, M., & Burt, A. (1995). Intrahepatic mast cells in chronic liver diseases. Hepatology, 22(4 PART 1), 1175-1181.
    DOI Scopus102 WoS99 Europe PMC63
    1995 Johnson, S., Toole, K., Fraser, R., Rogers, G., Dobbs, B., & Burt, A. (1995). Methylprednisolone does not inhibit the nonparenchymal cell responses to dimethylnitrosamine-induced liver injury. International Hepatology Communications, 4(4), 201-206.
    DOI
    1995 Teli, M., James, O., Burt, A., Bennett, M., & Day, C. (1995). The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology, 22(6), 1714-1719.
    DOI Scopus768 WoS663 Europe PMC509
    1995 Teli, M., Day, C., James, O., Burt, A., & Bennett, M. (1995). Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. The Lancet, 346(8981), 987-990.
    DOI Scopus344 WoS290 Europe PMC203
    1995 Leon, M., Kirby, J., Gibbs, P., Burt, A., & Bassendine, M. (1995). Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. Journal of Hepatology, 22(5), 591-595.
    DOI Scopus47 WoS47 Europe PMC27
    1995 FARRELL, D. (1995). Intrahepatic mast cells in chronic liver diseases*1. Hepatology, 22(4), 1175-1181.
    DOI
    1995 Macey, A., Burke, F., Abbott, K., Barton, N., Bradbury, E., Bradley, A., . . . Woodbridge, S. (1995). Outcomes of hand surgery. Journal of Hand Surgery, 20(6), 841-855.
    DOI Scopus125 Europe PMC74
    1995 REEVES, H., BURT, A., & DAY, C. (1995). MAPKINASE AND LIPID-DERIVED SIGNAL-TRANSDUCTION CASCADES IN HEPATIC STELLATE CELL-PROLIFERATION. HEPATOLOGY, 22(4), 693.
    1995 M-H Ho, A., Contardi, L., Day, C., Burt, A., & James, O. (1995). Pure alcoholic fatty liver and progression to cirrhosis or fibrosis. The Lancet, 346(8989), 1562-1563.
    DOI Scopus5 WoS3 Europe PMC4
    1994 BURT, A., HILLAN, K., MCLAUGHLIN, K., CHAPMAN, C., MATHEW, J., & BURR, A. (1994). HEPATOCYTE GROWTH-FACTOR LEVELS IN LIVER AND SERUM INCREASE DURING CHEMICAL HEPATOCARCINOGENESIS. HEPATOLOGY, 20(4), A274.
    1994 Johnson, S., Mathew, J., MacSween, R., Bennett, M., & Burt, A. (1994). Post-infantile giant cell hepatitis: Histological and immunohistochemical study. Journal of Clinical Pathology, 47(11), 1022-1027.
    DOI Scopus48 WoS35 Europe PMC27
    1994 Mathew, J., Hines, J., James, O., & Burt, A. (1994). Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury. Journal of Hepatology, 20(4), 537-541.
    DOI Scopus31 WoS25 Europe PMC19
    1994 TURNER, I., MYSZOR, M., MITCHISON, H., BENNETT, M., BURT, A., & JAMES, O. (1994). A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. Journal of Gastroenterology and Hepatology, 9(2), 162-168.
    DOI Scopus35 WoS38 Europe PMC28
    1994 Collier, J., Carpenter, M., Burt, A., & Bassendine, M. (1994). Expression of mutant p53 protein in hepatocellular carcinoma. Gut, 35(1), 98-100.
    DOI Scopus20 WoS21 Europe PMC9
    1994 MATHEW, J., HINES, J., TOOLE, K., JOHNSON, S., JAMES, O., & BURT, A. (1994). Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. Histopathology, 25(1), 65-70.
    DOI Scopus27 WoS30 Europe PMC18
    1994 TEILI, M., DAY, C., BURT, A., & JAMES, O. (1994). PATTERN OF STEATOSIS AND CONTINUED DRINKING PREDICT RISK OF PROGRESSION TO CIRRHOSIS IN PURE ALCOHOLIC FATTY LIVER. HEPATOLOGY, 20(4), A319.
    WoS1
    1994 BURR, A., TOOLE, K., MATHEW, J., HINES, J., CHAPMAN, C., & BURT, A. (1994). TRANSFORMING GROWTH-FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN EXPERIMENTAL HEPATOCARCINOGENESIS. HEPATOLOGY, 19(4), I46.
    DOI
    1994 REEVES, H., BURT, A., WOOD, S., JAMES, O., & DAY, C. (1994). LIPOCYTE ACTIVATION OCCURS IN THE ABSENCE OF HEPATITIS IN ALCOHOLIC LIVER-DISEASE AND CORRELATES WITH THE SEVERITY OF STEATOSIS. HEPATOLOGY, 20(4), A318.
    WoS2
    1994 COLLIER, J., MAJOR, G., BURT, A., & BASSENDINE, M. (1994). ANALYSIS OF DNA-REPAIR IN CIRRHOSIS OF DIFFERENT ETIOLOGIES. GUT, 35(5), A722.
    1993 Burt, A., Le Bail, B., Balabaud, C., & Bioulac-Sage, P. (1993). Morphologic investigation of sinusoidal cells. Seminars in Liver Disease, 13(1), 21-38.
    DOI Scopus51 WoS40 Europe PMC18
    1993 HINES, J., JOHNSON, S., & BURT, A. (1993). INVIVO RESPONSES OF MACROPHAGES AND PERISINUSOIDAL CELLS TO CHOLESTATIC LIVER-INJURY. AMERICAN JOURNAL OF PATHOLOGY, 142(2), 511-518.
    WoS139
    1993 BURT, A., HUBSCHER, S., & HINES, J. (1993). PECAM-1 (CD31) IS EXPRESSED BY SINUSOIDAL ENDOTHELIAL-CELLS AND ACTIVATED ITO CELLS (LIPOCYTES) IN HUMAN LIVER. HEPATOLOGY, 18(4), A198.
    DOI
    1993 BURT, A., & MacSWEEN, R. (1993). Bile duct proliferation—its true significance?. Histopathology, 23(6), 599-602.
    DOI Scopus41 WoS41 Europe PMC29
    1993 Day, C., Burt, A., Brown, A., Bennett, M., Farrell, D., James, O., & Yeaman, S. (1993). Plasma membrane form of phosphatidate phosphohydrolase: A possible role in signal transduction during liver fibrogenesis. Clinical Science, 85(3), 281-287.
    DOI Scopus4 WoS6 Europe PMC4
    1993 Harrison, D., & Burt, A. (1993). Pathology of alcoholic liver disease. Bailliere's Clinical Gastroenterology, 7(3), 641-662.
    DOI Scopus10 WoS11 Europe PMC5
    1993 Collier, J., Guo, K., Gullick, W., Bassendine, M., & Burt, A. (1993). Expression of transforming growth factor alpha in human hepatocellular carcinoma. Liver, 13(3), 151-155.
    DOI Scopus28 WoS31 Europe PMC14
    1993 Burt, A. (1993). Cellular and molecular aspects of hepatic fibrosis. Journal of Pathology, 170(2), 105-114.
    DOI Scopus132 WoS128 Europe PMC87
    1993 Burr, A., Carpenter, M., Hines, J., Gullick, W., & Burt, A. (1993). Intrahepatic distribution of transforming growth factor‐alpha (TGFα) during liver regeneration following carbon tetrachlorideinduced necrosis. The Journal of Pathology, 170(1), 95-100.
    DOI Scopus42 WoS45 Europe PMC25
    1993 Hines, J., Johnson, S., & Burt, A. (1993). In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. American Journal of Pathology, 142(2), 511-518.
    Scopus135 Europe PMC86
    1993 Collier, J., Guo, K., Bassendine, M., Major, G., & Burt, A. (1993). Deficient repair of DNA lesion O<sup>6</sup>-methylguanine in cirrhosis. The Lancet, 341(8839), 207-208.
    DOI Scopus12 WoS15 Europe PMC8
    1993 Franceschi, S., Boyle, P., Maisonneuve, P., La Vecchia, C., Burt, A., Kerr, D., & MacFarlane, G. (1993). The epidemiology of thyroid carcinoma.. Critical reviews in oncogenesis, 4(1), 25-52.
    Scopus152 WoS137 Europe PMC57
    1993 COLLIER, J., MAJOR, G., BURT, A., & BASSENDINE, M. (1993). CHARACTERIZATION OF THE DNA-REPAIR PROTEIN O6-METHYLGUANINE-DNA METHYLTRANSFERASE IN CIRRHOSIS. HEPATOLOGY, 18(4), A182.
    DOI
    1992 Burke, T., Seidler, R., & Smith, H. (1992). Untitled. MOLECULAR ECOLOGY, 1(1), 1.
    DOI WoS5
    1992 Johnson, S., Hines, J., & Burt, A. (1992). Phenotypic modulation of perisinusoidal cells following acute liver injury: A quantitative analysis. International Journal of Experimental Pathology, 73(6), 765-772.
    Scopus33 WoS34 Europe PMC24
    1992 GRIFFITHS, M., SHEPHERD, M., FERRIER, R., SCHUPPAN, D., JAMES, O., & BURT, A. (1992). Light microscopic and ultrastructural distribution of type VI collagen in human liver: alterations in chronic biliary disease. Histopathology, 21(4), 335-344.
    DOI Scopus22 WoS22 Europe PMC12
    1992 Burt, A. (1992). Liver fibrosis. British Medical Journal, 305(6853), 537-538.
    DOI Scopus6 WoS6 Europe PMC2
    1992 Boon, A., Hubscher, S., Lee, J., Hines, J., & Burt, A. (1992). Hepatic reinnervation following orthotopic liver transplantation in man. The Journal of Pathology, 167(2), 217-222.
    DOI Scopus30 WoS28 Europe PMC19
    1992 BLOXHAM, C., HENDERSON, D., HAMPSON, J., & BURT, A. (1992). Nodular regenerative hyperplasia of the liver in Behçet's disease. Histopathology, 20(5), 452-454.
    DOI Scopus3 WoS2 Europe PMC2
    1992 Allison, M., Mowat, A., McCruden, E., McGregor, E., Burt, A., Briggs, J., . . . Mills, P. (1992). The spectrum of chronic liver disease in renal transplant recipients. QJM, 83(2), 355-367.
    DOI Scopus17 WoS18 Europe PMC6
    1992 Collier, J., Guo, K., Mathew, J., May, F., Bennett, M., Corbett, I., . . . Burt, A. (1992). c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma. Journal of Hepatology, 14(2-3), 377-380.
    DOI Scopus45 WoS43 Europe PMC27
    1992 Johnson, S., Hines, J., & Burt, A. (1992). Immunolocalization of proliferating perisinusoidal cells in rat liver. The Histochemical Journal, 24(2), 67-72.
    DOI Scopus16 WoS20 Europe PMC14
    1992 Lee, J., Ahmed, Q., Hines, J., & Burt, A. (1992). Disappearance of hepatic parenchymal nerves in human liver cirrhosis. Gut, 33(1), 87-91.
    DOI Scopus37 WoS32 Europe PMC22
    1992 Mathew, J., Cattan, A., Hall, A., Hines, J., Nelson, R., Eastham, E., & Burt, A. (1992). Glutathione S-transferases in neonatal liver disease. Journal of Clinical Pathology, 45(8), 679-683.
    DOI Scopus17 WoS13 Europe PMC7
    1992 Epstein, M., Windebank, K., Burt, A., Thomas, L., & Cant, A. (1992). CD30 expression by peripheral blood monocytes and hepatic macrophages in a child with miliary tuberculosis. Journal of Clinical Pathology, 45(7), 638-639.
    DOI Scopus8 WoS8 Europe PMC7
    1992 Johnson, S., Hines, J., & Burt, A. (1992). Macrophage and perisinusoidal cell kinetics in acute liver injury. The Journal of Pathology, 166(4), 351-358.
    DOI Scopus105 WoS106 Europe PMC66
    1992 DAY, C., BROWN, A., BENNETT, M., BURT, A., JAMES, O., & YEAMAN, S. (1992). PLASMA-MEMBRANE PHOSPHATIDATE PHOSPHOHYDROLASE - A ROLE IN LIVER-REGENERATION. HEPATOLOGY, 16(4), A141.
    1992 TINIAKOS, D., HARRISON, D., & BURT, A. (1992). DETECTION OF MALLORY BODIES IN HUMAN LIVER BIOPSIES BY IMMUNOLOCALIZATION OF UBIQUITIN - COMPARISON WITH OTHER HISTOCHEMICAL AND IMMUNOHISTOCHEMICAL METHODS. HEPATOLOGY, 16(2), 601.
    WoS1
    1992 TINIAKOS, D., NIKOLAIDOU, A., MOUROUTI, G., LYRA, T., SPANDIDOS, D., & TINIAKOS, G. (1992). ONCOGENE EXPRESSION AND HBV/TUMOR MARKERS IN HUMAN LIVER-DISEASE. HEPATOLOGY, 16(2), 601.
    WoS1
    1992 GRIFFITHS, M., BURT, A., HILLAN, K., & MACSWEEN, R. (1992). LOCALIZATION OF TYPE-I PROCOLLAGEN MESSENGER-RNA IN RAT-LIVER. JOURNAL OF PATHOLOGY, 168, A149.
    1992 BURR, A., CARPENTER, M., & BURT, A. (1992). IMMUNOREACTIVE TRANSFORMING GROWTH FACTOR-ALPHA IN RAT-LIVER FOLLOWING ACUTE CARBON TETRACHLORIDE-INDUCED INJURY. HEPATOLOGY, 16(2), 520.
    1991 MATHEW, J., HALL, A., CATTAN, A., HINES, J., & BURT, A. (1991). GLUTATHIONE S-TRANSFERASES IN NEONATAL LIVER-DISEASE. JOURNAL OF PATHOLOGY, 163(2), A178.
    1991 JOHNSON, S., HINES, J., & BURT, A. (1991). PERISINUSOIDAL (ITO) CELL-PROLIFERATION AND PHENOTYPIC MODULATION IN ACUTE LIVER-INJURY. GUT, 32(7), A837.
    1991 COLLIER, J., GUO, K., GULLICK, W., CHALLEN, C., BURT, A., & BASSENDINE, M. (1991). TRANSFORMING GROWTH-FACTOR ALPHA (TGF-ALPHA) - A ROLE IN HUMAN HEPATOCARCINOGENESIS BY AN AUTOCRINE MECHANISM. HEPATOLOGY, 14(4), A110.
    1991 AHMED, Q., JOHNSON, S., HINES, J., & BURT, A. (1991). IMMUNOHISTOCHEMICAL LOCALIZATION OF PERISINUSOIDAL (ITO) CELLS IN HUMAN LIVER. JOURNAL OF PATHOLOGY, 163(2), A177.
    1991 LEE, J., AHMED, Q., HINES, J., & BURT, A. (1991). ALTERATIONS OF HEPATIC SINUSOIDAL INNERVATION IN LIVER-DISEASE. JOURNAL OF PATHOLOGY, 163(2), A178.
    1991 Griffiths, M., Keir, S., & Burt, A. (1991). Basement membrane proteins in the space of Disse: A reappraisal. Journal of Clinical Pathology, 44(8), 646-648.
    DOI Scopus18 WoS23 Europe PMC17
    1991 MURPHY, E., GRIFFITHS, M., HUNTER, J., & BURT, A. (1991). Fibrin‐ring granulomas: a non‐specific reaction to liver injury?. Histopathology, 19(1), 91-93.
    DOI Scopus16 WoS8 Europe PMC6
    1991 JOHNSON, S., HINES, J., & BURT, A. (1991). PROLIFERATION OF PERISINUSOIDAL (ITO) CELLS FOLLOWING ACUTE LIVER-INJURY. JOURNAL OF PATHOLOGY, 163(2), A170.
    1991 GRIFFITHS, M., SCHUPPAN, D., MACSWEEN, R., FERRIER, R., & BURT, A. (1991). LOCALIZATION OF TYPE-VI COLLAGEN IN NORMAL AND FIBROTIC LIVER. JOURNAL OF PATHOLOGY, 163(2), A178.
    1990 RAWEILY, E., GIBSON, A., & BURT, A. (1990). Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia. Histopathology, 17(6), 521-527.
    DOI Scopus51 WoS49 Europe PMC25
    1990 MYSZOR, M., TURNER, I., MITCHISON, H., BENNETT, M., BURT, A., & JAMES, O. (1990). NO SYMPTOMATIC OR HISTOLOGICAL BENEFIT FROM URSODEOXYCHOLIC ACID TREATMENT IN PBC AFTER 1 YEAR CONTROLLED PILOT-STUDY. HEPATOLOGY, 12(2), 415.
    WoS8
    1990 MOWAT, A., ALLISON, M., BURT, A., MILLS, P., BRIGGS, J., & MACSWEEN, R. (1990). CHRONIC LIVER-DISEASE IN RENAL-TRANSPLANT RECIPIENTS. JOURNAL OF PATHOLOGY, 160(2), A169.
    1990 RAWEILY, E., GIBSON, A., & BURT, A. (1990). INTRAHEPATIC CHOLANGIOPATHY IN EXTRAHEPATIC BILIARY ATRESIA. JOURNAL OF PATHOLOGY, 160(2), A164.
    1990 BURT, A., GRIFFITHS, M., SCHUPPAN, D., VOSS, B., & MACSWEEN, R. (1990). Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno‐gold labelling. Histopathology, 16(1), 53-58.
    DOI Scopus29 WoS32 Europe PMC20
    1989 Burt, A., Tiniakos, D., MacSween, R., Griffiths, M., Wisse, E., & Polak, J. (1989). Localization of adrenergic and neuropeptide tyrosine‐containing nerves in the mammalian liver. Hepatology, 9(6), 839-845.
    DOI Scopus53 WoS53 Europe PMC40
    1989 Goudie, B., Macfarlane, G., Boyle, P., Gillis, C., MacSween, R., & Watkinson, G. (1989). Risk Factors and Prognosis in Primary Biliary Cirrhosis. The American Journal of Gastroenterology, 84(7), 713-716.
    DOI Scopus61 WoS64 Europe PMC41
    1989 Hillan, K., Burt, A., George, W., Macsween, R., Griffiths, M., & Bradley, J. (1989). Intrasplenic hepatocyte transplantation in rats with experimental liver injury: Morphological and morphometric studies. The Journal of Pathology, 159(1), 67-73.
    DOI Scopus29 WoS34 Europe PMC22
    1989 BURT, A., GRIFFITHS, M., SCHUPPAN, D., VOSS, B., & MACSWEEN, R. (1989). LOCALIZATION OF TYPE-IV COLLAGEN IN HUMAN-LIVER USING IMMUNOELECTRON MICROSCOPY. JOURNAL OF PATHOLOGY, 157(2), A174.
    1989 Geerts, A., Vrijsen, R., Rauterberg, J., Burt, A., Schellinck, P., & Wisse, E. (1989). In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. Journal of Hepatology, 9(1), 59-68.
    DOI Scopus165 WoS199 Europe PMC122
    1988 BURT, A., GRIFFITHS, M., MACSWEEN, R., SCHUPPAN, D., & VOSS, B. (1988). IDENTIFICATION OF EXTRACELLULAR-MATRIX PROTEINS IN HUMAN-LIVER BIOPSIES USING AN IMMUNOGOLD TECHNIQUE. HEPATOLOGY, 8(5), 1302.
    1988 KERR, D., REED, N., MACFARLANE, G., BOYLE, P., & BURT, A. (1988). THE INFLUENCE OF TREATMENT ON SURVIVAL FROM WELL DIFFERENTIATED THYROID-CARCINOMA. BRITISH JOURNAL OF CANCER, 58(2), 272.
    1988 BURT, A., GRIFFITHS, M., POLAK, J., & MACSWEEN, R. (1988). PEPTIDERGIC INNERVATION OF THE MAMMALIAN LIVER. HEPATOLOGY, 8(5), 1295.
    WoS1
    1988 Verhoeven, D., Buyssens, N., Burt, A., & Macsween, R. (1988). Letters to the editor. The Journal of Pathology, 154(3), 287-288.
    DOI Scopus1 Europe PMC1
    1988 HILLAN, K., BURT, A., MACSWEEN, R., GEORGE, W., & BRADLEY, J. (1988). INTRASPLENIC HEPATOCYTE TRANSPLANTATION IN ANIMALS WITH EXPERIMENTAL LIVER-INJURY. HEPATOLOGY, 8(5), 1440.
    1988 BURT, A., & MACSWEEN, R. (1988). DESMIN-CONTAINING STELLATE CELLS IN THE RAT-LIVER - REPLY. JOURNAL OF PATHOLOGY, 154(3), 288.
    1988 GRIFFITHS, M., BURT, A., & MACSWEEN, R. (1988). LOCALIZATION OF EXTRACELLULAR-MATRIX PROTEINS IN HUMAN-LIVER BY IMMUNO-ELECTRON MICROSCOPY. JOURNAL OF PATHOLOGY, 154(1), A78.
    1988 HILLAN, K., BURT, A., BRADLEY, J., GEORGE, W., & MACSWEEN, R. (1988). INTRASPLENIC HEPATOCYTE TRANSPLANTATION IN EXPERIMENTAL LIVER-INJURY - MORPHOMETRICAL AND MORPHOLOGICAL-STUDIES. JOURNAL OF PATHOLOGY, 154(1), A77.
    1987 GOUDIE, B., MACFARLANE, G., BOYLE, P., BURT, A., GILLIS, C., MACSWEEN, R., & WATKINSON, G. (1987). EPIDEMIOLOGY OF ANTIMITOCHONDRIAL ANTIBODY SEROPOSITIVITY AND PRIMARY BILIARY-CIRRHOSIS IN THE WEST OF SCOTLAND. GUT, 28(10), A1346.
    WoS13
    1987 BURT, A., TINIAKOS, D., MACSWEEN, R., & POLAK, J. (1987). LOCALIZATION OF NEUROPEPTIDE Y CONTAINING NORADRENERGIC NERVES IN MAMMALIAN LIVER. JOURNAL OF PATHOLOGY, 151(1), A67.
    1987 HILLAN, K., BURT, A., MACSWEEN, R., GEORGE, W., & BRADLEY, J. (1987). TRANSPLANTATION OF ISOLATED HEPATOCYTES INTO ANIMALS WITH EXPERIMENTAL LIVER-INJURY. JOURNAL OF HEPATOLOGY, 5, S144.
    1987 BURT, A., GILLON, M., WISSE, E., POLAK, J., & MACSWEEN, R. (1987). DISTRIBUTION OF CALCITONIN GENE RELATED PEPTIDE (CGRP) AND SUBSTANCE P-CONTAINING NERVES IN LIVER - AN IMMUNOHISTOCHEMICAL STUDY. GUT, 28(10), A1330.
    WoS3
    1987 Kerr, D., Burt, A., & Anderson, J. (1987). Tumours of the diffuse endocrine system. European Journal of Surgical Oncology, 13(3), 189-195.
    Scopus6 WoS4 Europe PMC3
    1987 MacSween, R., Burt, A., & Haboubi, N. (1987). Unusual variant of primary sclerosing cholangitis. Journal of Clinical Pathology, 40(5), 541-545.
    DOI Scopus5 WoS7 Europe PMC5
    1987 Burt, A., Seywright, M., & George, W. (1987). Mixed apocrine-medullary carcinoma of the breast. Report of a case with fine needle aspiration cytology. Acta Cytologica, 31(3), 322-324.
    Scopus7 WoS6 Europe PMC3
    1987 Burt, A., MacGuire, J., Lindop, G., & Browne, M. (1987). Mixed follicular-parafollicular carcinoma of the thyroid. Scottish Medical Journal, 32(2), 50-51.
    DOI Scopus6 WoS3
    1987 Burt, A., Stewart, J., Aitchison, M., & Macsween, R. (1987). Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: Changes in liver disease. Journal of Clinical Pathology, 40(7), 719-724.
    DOI Scopus26 WoS24 Europe PMC15
    1987 Burt, A., Cooper, G., MacKay, C., & Boyd, J. (1987). Dermoid cyst of the testis. Scottish Medical Journal, 32(5), 146-148.
    DOI Scopus8 WoS6 Europe PMC6
    1987 CONNELL, J., CORDER, R., ASBURY, J., MACPHERSON, S., INGLIS, G., LOWRY, P., . . . SEMPLE, P. (1987). NEUROPEPTIDE Y IN MULTIPLE ENDOCRINE NEOPLASIA: RELEASE DURING SURGERY FOR PHAEOCHROMOCYTOMA. Clinical Endocrinology, 26(1), 75-84.
    DOI Scopus12 WoS12 Europe PMC10
    1987 BURT, A., STEWART, J., & MACSWEEN, R. (1987). IMMUNOLOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) IN HUMAN-LIVER BIOPSIES. JOURNAL OF PATHOLOGY, 151(1), A67.
    1987 HILLAN, K., BURT, A., GEORGE, W., & BRADLEY, J. (1987). FAILURE OF HEPATOCYTE TRANSPLANTATION TO IMPROVE SURVIVAL IN AN EXPERIMENTAL-MODEL OF CHRONIC LIVER-INJURY. JOURNAL OF HEPATOLOGY, 5, S144.
    1986 BURT, A., TINIAKOS, D., MACSWEEN, R., & POLAK, J. (1986). NEUROPEPTIDE TYROSINE (NPY) IMMUNOREACTIVITY IN INTRAHEPATIC NERVES IN RAT AND HUMAN-LIVER. JOURNAL OF PATHOLOGY, 148(1), A67.
    1986 Goudie, B., Burt, A., Macfarlane, G., Birnie, G., Macsween, R., & Watkinson, G. (1986). Breast cancer in women with primary biliary cirrhosis. British Medical Journal (Clinical research ed.), 292(6516), 341.
    DOI
    1986 Burt, A., & MacSween, R. (1986). Hepatic vein lesions in alcoholic liver disease: Retrospective biopsy and necropsy study. Journal of Clinical Pathology, 39(1), 63-67.
    DOI Scopus45 WoS35 Europe PMC22
    1986 Burt, A., Robertson, J., Heir, J., & Macsween, R. (1986). Desmin‐containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury. The Journal of Pathology, 150(1), 29-35.
    DOI Scopus102 WoS117 Europe PMC71
    1986 Kerr, D., Burt, A., Boyle, P., MacFarlane, G., Storer, A., & Brewin, T. (1986). Prognostic factors in thyroid tumours. British Journal of Cancer, 54(3), 475-482.
    DOI Scopus34 WoS40 Europe PMC22
    1986 GOUDIE, B., BURT, A., MACFARLANE, G., BIRNIE, G., MACSWEEN, R., WATKINSON, G., . . . GILLIS, C. (1986). BREAST-CANCER IN WOMEN WITH PRIMARY BILIARY-CIRRHOSIS - REPLY. BRITISH MEDICAL JOURNAL, 292(6516), 340-341.
    DOI Europe PMC1
    1986 Hollman, A., Morley, P., Burt, A., & Davidson, J. (1986). Biliary tract dilatation in acquired immune deficiency syndrome. European Journal of Radiology, 6(4), 309-310.
    Scopus1 WoS4 Europe PMC1
    1986 MacSween, R., & Burt, A. (1986). Histologic spectrum of alcoholic liver disease. Seminars in Liver Disease, 6(3), 221-232.
    DOI Scopus176 WoS161 Europe PMC112
    1986 Burt, A., Smillie, D., Cowan, M., & Adams, F. (1986). Fine needle aspiration cytology: experience with a cell block technique.. Journal of clinical pathology, 39(1), 114-115.
    DOI Scopus13 WoS15 Europe PMC9
    1986 Kerr, D., Burt, A., Beastall, G., & Holloway, C. (1986). The effect of 5-fluorouracil on rat adrenal function. Medical Oncology and Tumor Pharmacotherapy, 3(2), 101-104.
    DOI Scopus1 WoS1 Europe PMC1
    1986 ROBERTSON, J., BURT, A., & MACSWEEN, R. (1986). MORPHOMETRICAL STUDY OF DESMIN-CONTAINING NONPARENCHYMAL CELLS IN EXPERIMENTAL ACUTE LIVER-INJURY. JOURNAL OF PATHOLOGY, 148(1), A66.
    1986 BURT, A., STEWART, J., & MACSWEEN, R. (1986). IMMUNOLOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) IN HUMAN-LIVER BIOPSIES. HEPATOLOGY, 6(4), 802.
    1986 GOUDIE, B., BURT, A., MACFARLANE, G., BOYLE, P., MACSWEEN, R., WATKINSON, G., & GILLIS, C. (1986). FACTORS AFFECTING THE PROGNOSIS OF PRIMARY BILIARY-CIRRHOSIS. DIGESTIVE DISEASES AND SCIENCES, 31(10), S476.
    1986 PLUMB, J., WILMOTT, N., KERR, D., BURT, A., MORE, I., & KAYE, S. (1986). FLUORESCENT MICROSCOPIC STUDIES ON THE DIFFERENTIAL CELLULAR-DISTRIBUTION OF ADRIAMYCIN AND 4'-DEOXYDOXORUBICIN. BRITISH JOURNAL OF CANCER, 53(3), 440.
    1986 BURT, A., ROBERTSON, J., & MACSWEEN, R. (1986). IDENTIFICATION OF DESMIN-CONTAINING NONPARENCHYMAL CELLS IN RAT-LIVER. JOURNAL OF PATHOLOGY, 148(1), A65-A66.
    1986 GOUDIE, B., BURT, A., MACFARLANE, G., BOYLE, P., MACSWEEN, R., GILLIS, C., & WATKINSON, G. (1986). THE NATURAL-HISTORY OF PRIMARY BILIARY-CIRRHOSIS. SCOTTISH MEDICAL JOURNAL, 31(1), 60.
    1985 BURT, A., & MACSWEEN, R. (1985). VENO-OCCLUSIVE LESIONS IN ALCOHOLIC LIVER-DISEASE. JOURNAL OF PATHOLOGY, 145(1), A87.
    1985 BURT, A., BROWN, I., KERR, D., & BOYLE, P. (1985). IMMUNOHISTOCHEMICAL DEMONSTRATION OF EPITHELIAL AND LYMPHOID MARKERS IN ANAPLASTIC THYROID-TUMORS. SCOTTISH MEDICAL JOURNAL, 30(1), 56.
    1985 BURT, A., KERR, D., BROWN, I., & BOBROW, L. (1985). HISTOGENESIS OF ANAPLASTIC THYROID-TUMORS. BRITISH JOURNAL OF CANCER, 52(3), 447-448.
    1985 Burt, A., Kerr, D., Brown, I., & Boyle, P. (1985). Lymphoid and epithelial markers in small cell anaplastic thyroid tumours. Journal of Clinical Pathology, 38(8), 893-896.
    DOI Scopus15 WoS19 Europe PMC10
    1985 Kerr, D., Burt, A., Brewin, T., & Boyle, P. (1985). DIVERGENCE BETWEEN MORTALITY AND INCIDENCE RATES OF THYROID CANCER IN SCOTLAND. The Lancet, 326(8447), 149.
    DOI Scopus5 WoS8 Europe PMC3
    1985 MacSween, R., & Burt, A. (1985). The cellular pathology of primary biliary cirrhosis. Molecular Aspects of Medicine, 8(3), 269-291.
    DOI Scopus15 WoS12 Europe PMC7
    1985 Goudie, B., Burt, A., Macfarlane, G., Birnie, G., Mills, P., Macsween, R., . . . Gillis, C. (1985). Breast cancer in women with primary biliary cirrhosis. British Medical Journal (Clinical research ed.), 291(6509), 1597-1598.
    DOI Scopus52 WoS50 Europe PMC30
    1984 Burt, A., & Goudie, R. (1984). Thyroglobulin in carcinoma of the thyroid. Human Pathology, 15(2), 197-198.
    DOI Scopus3 WoS4 Europe PMC3
    1984 Burt, A., Scott, G., Shiach, C., & Isles, C. (1984). Acquired immunodeficiency syndrome in a patient with no known risk factors: A pathological study. Journal of Clinical Pathology, 37(4), 471-474.
    DOI Scopus17 WoS25 Europe PMC15
    1984 Behan, W., & Burt, A. (1984). HTLV-III SEROPOSITIVITY IN AIDS. The Lancet, 323(8389), 1292.
    DOI Scopus1 WoS2 Europe PMC1
    1984 Shiach, C., Burt, A., Isles, C., & Ball, S. (1984). Pyrexia of undetermined origin, diarrhoea, and primary cerebral lymphoma associated with acquired immunodeficiency. British Medical Journal, 288(6415), 449-450.
    DOI Scopus11 WoS7 Europe PMC6
    1984 BURT, A., BROWN, I., STEWART, J., & KERR, D. (1984). IMMUNOHISTOCHEMICAL STUDY OF ANAPLASTIC SMALL CELL TUMORS OF THYROID. JOURNAL OF PATHOLOGY, 143(4), A296.
    1982 Burt, A., Anthony, R., Hislop, W., Bouchier, I., & MacSween, R. (1982). Liver membrane antibodies in alcoholic liver disease: I. Prevalence and immunoglobulin class. Gut, 23(3), 221-225.
    DOI Scopus33 WoS37 Europe PMC19
    1981 MacSween, R., Burt, A., Anthony, R., & Hislop, W. (1981). Liver membrane antibodies in alcoholic liver disease. Journal of Pathology, 134(4), 332.
    1980 Burt, A., MacSween, R., Galbraith, I., & Hislop, W. (1980). Liver membrane antibodies in alcoholic liver disease. Scottish Medical Journal, 25(2), 163-164.
    DOI Scopus4
    1979 BURT, A., & GOUDIE, R. (1979). Diagnosis of primary thyroid carcinoma by immunohistological demonstration of thyroglobulin. Histopathology, 3(4), 279-286.
    DOI Scopus63 WoS75 Europe PMC44
  • Books

    Year Citation
    2018 Burt, A. D., Ferrell, L. D., & Hübscher, S. G. (Eds.) (2018). MacSween's Pathology of the Liver (7 ed.).
    Scopus8
    2018 Burt, A. D., Ferrell, L. D., & Hübscher, S. G. (Eds.) (2018). MacSween's Pathology of the Liver (7 ed.).
    Scopus8
    2011 Burt, A., Portmann, B., & Ferrell, L. (Eds.) (2011). MacSween's pathology of the liver (6 ed.). Churchill Livingstone/​Elsevier.
    DOI Scopus43
    2011 Burt, A., Portmann, B., & Ferrell, L. (Eds.) (2011). MacSween's pathology of the liver (6 ed.). Churchill Livingstone/​Elsevier.
    DOI Scopus43
  • Book Chapters

    Year Citation
    2018 Tiniakos, D., Anstee, Q., & Burt, A. (2018). Fatty Liver Disease. In A. Burt, L. Ferrell, & S. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. 308-371). Elsevier.
    DOI Scopus3
    2018 Burt, A., Ferrell, L., & Hübscher, S. (2018). Preface. In A. Burt, L. Ferrell, & S. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. v-vi). Elselvier.
    DOI
    2018 Bellamy, C., & Burt, A. (2018). The Liver in Systemic Disease. In A. Burt, L. Ferrell, & S. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. 966-1018). Elsevier.
    DOI Scopus1
    2012 Brunt, E., Neuschwander-Tetri, B., & Burt, A. (2012). Fatty liver disease. Alcoholic and non-alcoholic. In MacSween's Pathology of the Liver (pp. 293-359).
    DOI Scopus22
    2012 Quaglia, A., Burt, A., Ferrell, L., & Portmann, B. (2012). Systemic disease. In MacSween's Pathology of the Liver (pp. 935-986).
    DOI Scopus1
    2012 Crawford, J., & Burt, A. (2012). Anatomy, pathophysiology and basic mechanisms of disease. In MacSween's Pathology of the Liver (pp. 1-77).
    DOI Scopus18
    2012 Burt, A. D., Portmann, B. C., & Ferrell, L. D. (2012). Preface. In A. D. Burt, B. C. Portmann, & L. D. Ferrell (Eds.), MacSween's pathology of the liver (6 ed., pp. xi). Elsevier.
    DOI
  • Conference Papers

    Year Citation
    2018 Pu, L. Z. C. T., Campbell, B., Burt, A. D., Carneiro, G., & Singh, R. (2018). COMPUTER-AIDED DIAGNOSIS FOR CHARACTERISING COLORECTAL LESIONS: INTERIM RESULTS OF A NEWLY DEVELOPED SOFTWARE. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB245). Washington, DC: MOSBY-ELSEVIER.
    2018 Pu, L. Z. C. T., Lu, K., Ovenden, A., Edwards, S., Wilson, B., Carneiro, G., . . . Singh, R. (2018). EFFECT OF TRAINING AND TIME OF THE DAY ON POLYP DETECTION RATES IN AUSTRALIA. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB161). Washington, DC: MOSBY-ELSEVIER.
    2018 Pu, L. Z. C. T., Koay, D. S., Ovenden, A., Singh, G., Rana, K., Burt, A. D., & Singh, R. (2018). OPTICAL EVALUATION OF SCARS AFTER EMR USING NBI WITH DUAL FOCUS AND UNDERWATER TECHNIQUE (UNBI-DF): INTERIM ANALYSIS. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB377). Washington, DC: MOSBY-ELSEVIER.
    2017 Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study assessing associated factors in patients with colon polyps: interim analysis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 253-254). WILEY.
    2017 Pu, L., Koay, D., Ovenden, A., Burt, A., & Singh, R. (2017). Prospective study to evaluate scars after colorectal endoscopic mucosal resection using narrow-band imaging with dual focus and underwater technique: Interim analysis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 33-34). WILEY.
    2017 Pu, L., Campbell, B., Carneiro, G., Burt, A., & Singh, R. (2017). Computer-aided diagnosis (CAD) for characterizing colorectal lesions: Initial results of newly developed software. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 34-35). WILEY.
    2017 Pu, L., Koay, D., Ovenden, A., Burt, A., & Singh, R. (2017). Prospective study predicting histology in colorectal lesions: Interim analysis of the NICE, JNET, and MS classifications. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 34). WILEY.
    2017 Pu, L., Koay, D., Ovenden, A., Burt, A., & Singh, R. (2017). Prospective study assessing associated factors in patients with colon polyps: Interim analysis. In Abstracts of the Gastroenterological Society of Australia Australian Gastroenterology Week Precision Medicine in Gastroenterology, as published in Journal of Gastroenterology and Hepatology Vol. 32 (pp. 33-34). Gold Coast, QLD: Wiley.
    DOI
    2011 McPherson, S., Anstee, Q., Henderson, E., Burt, A., & Day, C. (2011). ARE SIMPLE NON-INVASIVE SCORING SYSTEMS FOR FIBROSIS RELIABLE IN PATIENTS WITH NAFLD AND NORMAL ALT LEVELS?. In GUT Vol. 60 (pp. A54-A55). BMJ PUBLISHING GROUP.
    DOI
    2011 Tanwar, S., Trembling, P. M., Guha, I. N., Parkes, J., Kaye, P., Burt, A. D., . . . Rosenberg, W. M. (2011). VALIDATION OF A NOVEL BIOMARKER MODEL FOR THE PREDICTION OF NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. In HEPATOLOGY Vol. 54 (pp. 1123A). San Francisco, CA: WILEY-BLACKWELL.
    2011 Leavitt, M., Burt, A., Hu, W., Canty, D., Gray, M., Bray, A., . . . Quinn, A. (2011). RECOMBINANT LYSOSOMAL ACID LIPASE NORMALIZES LIVER WEIGHT, TRANSAMINASES AND HISTOPATHOLOGICAL ABNORMALITIES IN AN IN VIVO MODEL OF CHOLESTERYL ESTER STORAGE DISEASE. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S358). Berlin, GERMANY: ELSEVIER SCIENCE BV.
    DOI WoS9
    2011 Robinson, S., Mann, J., Burt, A., Manas, D., Mann, D., & White, S. (2011). Pathogenesis of chemotherapy associated liver injury prior to major hepatic resection. In BRITISH JOURNAL OF SURGERY Vol. 98 (pp. 20). Royal Coll Surgery, Dublin, IRELAND: WILEY-BLACKWELL.
    2011 Wallace, K., Shaw, J., White, S., Wright, S., Burt, A., & Wright, M. (2011). PROLONGED GLUCOCORTICOID EXPOSURE RESULTS IN THE APPEARANCE OF HEPATOCYTES IN THE ADULT PANCREAS. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S435). Berlin, GERMANY: ELSEVIER SCIENCE BV.
    2011 Jennings, N., Burt, A., & Griffin, S. (2011). Lymph node metastases in early oesophageal adenocarcinoma. In BRITISH JOURNAL OF SURGERY Vol. 98 (pp. 91). Bournemouth, ENGLAND: WILEY-BLACKWELL.
    2011 Zeybel, M., Oakley, F., Burt, A., Mann, D., & Mann, J. (2011). PROTECTIVE ADAPTATION TO LIVER FIBROSIS IN A SINGLE GENERATION BY HERITABLE EPIGENETIC MODIFICATIONS. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S52-S53). Berlin, GERMANY: ELSEVIER SCIENCE BV.
    DOI
    2011 Koshy, A., Knisely, A., Robinson, S., White, S., & Burt, A. (2011). Bile Canalicular Protein Expression is Altered in Chemotherapy-induced Sinusoidal Obstruction Syndrome (SOS). In JOURNAL OF PATHOLOGY Vol. 224 (pp. S37). Univ Ghent, Dept Pathol, Onderbergen, BELGIUM: WILEY-BLACKWELL.
    2011 Brain, J., Burt, A., Kirby, J., & Robertson, H. (2011). Investigation of the Fate of Cholangiocytes in Cholestatic Liver Disease. In JOURNAL OF PATHOLOGY Vol. 224 (pp. S22). Univ Cambridge, Dept Pathol, Cambridge, ENGLAND: WILEY-BLACKWELL.
    2011 McPherson, S., Anstee, Q. M., Henderson, E., Burt, A. D., & Day, C. P. (2011). ARE SIMPLE NON-INVASIVE SCORING SYSTEMS FOR FIBROSIS RELIABLE IN PATIENTS WITH NAFLD AND NORMAL ALT LEVELS?. In HEPATOLOGY Vol. 54 (pp. 1125A). San Francisco, CA: WILEY-BLACKWELL.
    WoS1
    2010 Mann, J., Oakley, F., Burt, A. D., Tsukamoto, H., & Mann, D. (2010). EPIGENETIC REGULATION OF PRO-FIBROGENIC GENES INVOLVED IN HEPATIC STELLATE CELL ACTIVATION AND LIVER FIBROSIS. In HEPATOLOGY Vol. 52 (pp. 1267A). Boston, MA: WILEY-BLACKWELL.
    2010 Chakraborty, J. B., Mann, J., Oakley, F., Burt, A. D., & Mann, D. A. (2010). NF-KB1 (P50) PROTECTS AGAINST GROWTH OF HEPATOCELLULAR CARCINOMA BY SUPPRESSING ROS, INHIBITING HEPATIC PHOSPHOSTAT3 AND STIMULATING PHOSPHOP38 alpha. In HEPATOLOGY Vol. 52 (pp. 593A). Boston, MA: WILEY-BLACKWELL.
    2010 Wright, M. C., Wallace, K., Shaw, J. A., Burt, A. D., & White, S. A. (2010). Long term glucocorticoid therapy leads to pancreatic acinar trans-differentiation into hepatocyte-like cells. In BRITISH JOURNAL OF SURGERY Vol. 97 (pp. 28). Royal Free Hosp, London, ENGLAND: JOHN WILEY & SONS LTD.
    2010 White, S. A., Shaw, J. A., Flecknell, P. A., Burt, A. D., & Wright, M. C. (2010). Chronic elevated systemic glucocorticoid results in widespread pancreatic-hepatic trans-differentiation in vivo. In TOXICOLOGY Vol. 278 (pp. 347). Herriot Watt Univ, Edinburgh, ENGLAND: ELSEVIER IRELAND LTD.
    DOI
    2009 Mann, J., Xu, X., Oakley, F., Maxwell, A., Elsharkawy, A. M., Mann, D. A., & Burt, A. D. (2009). EPIGENETICALLY INHERITED RESISTANCE TO LIVER FIBROSIS. In HEPATOLOGY Vol. 50 (pp. 849A-850A). Boston, MA: JOHN WILEY & SONS INC.
    WoS2
    2009 McGee, K., Harte, A., Hill, M., Burt, A., Kumar, S., Day, C., & McTernan, P. (2009). Circulating visfatin levels reduced in patients with non-alcoholic fatty liver disease irrespective of type 2 diabetes mellitus status. In DIABETOLOGIA Vol. 52 (pp. S20-S21). Vienna, AUSTRIA: SPRINGER.
    2009 Al-Rifai, A., Henderson, E., De Alwis, N., Burt, A. D., Day, C. P., & Stewart, S. (2009). STEATOSIS AND INFLAMMATION ARE TOGETHER ASSOCIATED WITH FIBROSIS PROGRESSION IN PATIENTS WITH NASH. In HEPATOLOGY Vol. 50 (pp. 802A). Boston, MA: JOHN WILEY & SONS INC.
    2009 Wallace, K., White, S. A., Shaw, J. A., Burt, A. D., & Wright, M. C. (2009). CHRONIC ELEVATED SYSTEMIC GLUCOCORTICOCOID RESULTS IN WIDESPREAD PANCREATIC-HEPATIC TRANS-DIFFERENTIATION IN VIVO. In HEPATOLOGY Vol. 50 (pp. 899A). Boston, MA: JOHN WILEY & SONS INC.
    2009 Gieling, R. G., Rajasekaran, V., Jurk, D., Elsharkawy, A. M., Burt, A. D., Oakley, F., & Mann, D. A. (2009). THE ANTI-INFLAMMATORY AND ANTI-PROLIFERATIVE PROPERTIES OF THE NFKB1 (P50) GENE PROTECT AGAINST HEPATOCELLULAR CARCINOMA. In HEPATOLOGY Vol. 50 (pp. 881A). Boston, MA: JOHN WILEY & SONS INC.
    2008 Marshall, H., Robertson, H., Burt, A., Jones, D., Kirby, J., & Hudson, M. (2008). Biliary epithelial to mesenchymal transition contributes to portal tract fibrogenesis in primary sclerosing cholangitis. In GUT Vol. 57 (pp. A50-A51). Brimingham, ENGLAND: B M J PUBLISHING GROUP.
    2008 Elsharkawy, A., Gieling, R., Oakley, F., Kendall, T., Burt, A., & Mann, D. (2008). Attenuated inflammatory response in fibrotic livers of mice lacking the c-Rel subunit of NF-kB. In JOURNAL OF HEPATOLOGY Vol. 48 (pp. S22-S23). Milan, ITALY: ELSEVIER SCIENCE BV.
    DOI
    2008 Kendrick, S., Leathart, J. B., Henderson, E., De Alwis, N., Stewart, S., Burt, A. D., . . . Day, C. P. (2008). A 'LOSS-OF-FUNCTION' MUTATION IN TIRAP, THE GENE ENCODING THE TOLL-LIKE RECEPTOR ADAPTER MOLECULE MAL PROTECTS AGAINST FIBROSIS IN NAFLD BUT NOT ALD. In HEPATOLOGY Vol. 48 (pp. 334A-335A). San Francisco, CA: JOHN WILEY & SONS INC.
    WoS1
    2007 Newton, J. L., Jones, D. E., Kane, L., Henderson, E., Pairman, J., Wilton, K., . . . Day, C. P. (2007). Fatigue in NAFLD is severe and associates with excessive daytime somnolence but not with liver disease severity or insulin resistance. In HEPATOLOGY Vol. 46 (pp. 742A-743A). Boston, MA: JOHN WILEY & SONS INC.
    2007 van der Laan, L., Thomas, R., Zondervan, P., Lindsay, A., Burt, A., Hudson, M., . . . Metselaar, H. (2007). The effect of calcineurin inhibitor usage on hepatic fibrosis progression in HCV-positive liver transplant recipients: A two-centre study.. In LIVER TRANSPLANTATION Vol. 13 (pp. S152). Rio de Janeiro, BRAZIL: JOHN WILEY & SONS INC.
    WoS1
    2006 Price, D., Donaldson, P., Ann, D., Leathart, J., Burt, A., Schmid, M., & Bassendine, M. (2006). Microsomal triglyceride transfer protein gene promoter polymorphism (493g allele) is associated with severity of hcv-associated steatosis.. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S151). Paris, FRANCE: ELSEVIER SCIENCE BV.
    DOI
    2006 Rygiel, K., Robertson, H., Burt, A., Jones, D., & Kirby, J. (2006). Demonstration of the transition of intrahepatic biliary epithelial cells to fibroblasts during chronic inflammatory liver diseases. In JOURNAL OF HEPATOLOGY Vol. 44 (pp. S241). Vienna, AUSTRIA: ELSEVIER SCIENCE BV.
    DOI WoS5
    2006 Price, D., Burt, A., Schmid, M., Craig, W., & Bassendine, M. (2006). Steatosis in chronic HCV infection: viral and host characteristics. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S127-S128). Paris, FRANCE: ELSEVIER SCIENCE BV.
    DOI
    2006 Price, D., Schmid, M., Agarwal, K., Hewett, M., Craig, W., Burt, A., & Bassendine, M. (2006). Chronic hepatitis C in injecting drug users: a comparison with non-injecting drug users in the same geographic area. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S212). Paris, FRANCE: ELSEVIER SCIENCE BV.
    DOI
    2005 Robertson, H., Xu, X., Burt, A., & Kirby, J. (2005). Epithelial to mesenchymal transition in chronic cholestatic liver disease. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 30). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD.
    WoS1
    2005 Burt, A. (2005). Vascular tumours. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 58). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD.
    2005 El-Refaie, A., Agarwal, K., & Burt, A. (2005). Ductular reaction in early post-transplant liver biopsies: effects of immunosuppression. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 29). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD.
    2005 El-Refaie, A., & Burt, A. (2005). Ductular reaction in the post-transplanted liver: a component of cellular rejection. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 2). London, ENGLAND: JOHN WILEY & SONS LTD.
    2005 Nielsen, S., Burt, A., Martin, C., Bassendine, M., & Toms, G. (2005). Human hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral-particles. In ATHEROSCLEROSIS Vol. 182 (pp. S6-S7). Univ Glamorgan, Pontypridd, WALES: ELSEVIER IRELAND LTD.
    2005 Zhao, L., Robertson, H., Kirby, J., Jones, D., & Burt, A. (2005). Epithelial-mesenchymal transition in portal fibrosis. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 1). London, ENGLAND: JOHN WILEY & SONS LTD.
    2005 Xu, X., Bulmer, J., & Burt, A. (2005). Mast cells in human decidua and trophoblast: alternations in placental pathology. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 5). London, ENGLAND: JOHN WILEY & SONS LTD.
    2005 Malcolm, P., Mathew, J., Walker, M., & Burt, A. (2005). Distinctive pattern of liver histology in poorly controlled type I diabetes. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 29). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD.
    2005 Nielsen, S., Burt, A., Martin, C., Bassendine, M., & Toms, G. (2005). Hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral particles. In HEPATOLOGY Vol. 42 (pp. 563A). San Francisco, CA: JOHN WILEY & SONS INC.
    2005 Stark, F., Smith, D., & Burt, A. (2005). Pathogenesis of peribiliary gland hamartomas revisited. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 17). London, ENGLAND: JOHN WILEY & SONS LTD.
    2004 Price, D., Bassendine, M., Gouldin, C., Norris, S., Toms, G., Schmid, M., . . . Donaldson, P. (2004). Apolipoprotein E2 protects against persistent hepatitis C virus infection.. In HEPATOLOGY Vol. 40 (pp. 445A). Boston, MA: JOHN WILEY & SONS INC.
    2004 Stewart, S., Jones, D., Vidali, M., Haugk, B., Burt, A., Albano, E., & Day, C. (2004). Correlation between anti-CYP2E1 titre and lymphocyte infiltration in ALD - An autoimmune disease in some patients?. In JOURNAL OF HEPATOLOGY Vol. 40 (pp. 176-177). Berlin, GERMANY: ELSEVIER SCIENCE BV.
    DOI WoS4
    2004 Price, D., Burt, A., Turner, A., Craig, W., Schmid, M., & Bassendine, M. (2004). Host and viral characteristics associated with steatosis in chronic hepatitis C. In GUT Vol. 53 (pp. A82-A83). Glasgow, Scotland: B M J PUBLISHING GROUP.
    2004 Zhao, L., & Burt, A. (2004). Expansion of hepatic stellate cell populations occurs in response to primary and metastatic liver tumours. In JOURNAL OF PATHOLOGY Vol. 204 (pp. 8A). Vrije Univ Med Ctr, Dept Pathol, Amstedram, NETHERLANDS: JOHN WILEY & SONS LTD.
    2003 Stewart, S., Daly, A., Chen, Y., Leathart, J., Haugk, B., Jones, D., . . . Day, C. (2003). Evidence that alcoholic liver disease is due to immune mechanisms in genetically susceptible drinkers. In GUT Vol. 52 (pp. 2 pages). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP.
    2003 Nielson, S., Burt, A., Martin, C., Bassendine, M., & Toms, G. (2003). Association of HCV particles with LDL/VLDL: Analysis using isotonic iodixanol gradient centrifugation & real time PCR.. In HEPATOLOGY Vol. 38 (pp. 670A-671A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
    2003 Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., . . . Day, C. (2003). Oxidative stress is an independent risk factor for the progression of non-alcoholic fatty liver disease (NAFLD) to advanced fibrosis.. In HEPATOLOGY Vol. 38 (pp. 506A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
    2003 Hicks, A., Burt, A., Thompson, M., & Day, C. (2003). Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells. In GUT Vol. 52 (pp. 2 pages). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP.
    2003 Zhao, L., & Burt, A. (2003). Neural and muscle proteins in hepatic stellate cells and mesenchymal cells of other mammalian tissues. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 22A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD.
    2003 Igbokwe, U., Gould, D., Burt, A., & Mathew, J. (2003). Methotrexate, psoriasis and alpha(1)-antitrypsin deficiency: a cocktail for liver fibrosis?. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 20A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD.
    2003 El-Refaie, A., & Burt, A. (2003). Mast cells in liver allograft rejection. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 22A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD.
    2003 Leong, M., Burt, A., Gould, D., Bowers, P., & Mathew, J. (2003). Haemochromatosis and methotrexate: inviting liver fibrosis?. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 20A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD.
    2003 Price, D., Agawal, K., Hewett, M., Craig, W., Schmid, M., Turner, A., . . . Bassendine, M. (2003). The hepatitis C virus (HCV) epidemic; spectrum of chronic liver disease in a single UK centre. In GUT Vol. 52 (pp. 1 page). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP.
    2003 Saksena, S., Leathart, J., Burt, A., James, O., Daly, A., & Day, C. (2003). Genetic evidence supporting the two-hit model of NASH pathogenesis. In GUT Vol. 52 (pp. 1 page). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP.
    2002 Crompton, D., Chinnery, P., Fey, C., Curtis, A., Morris, C., Kierstan, J., . . . Burn, J. (2002). Neuroferritinopathy: A window on the role of iron in neurodegeneration. In Blood cells, molecules &amp; diseases Vol. 29 (pp. 522-531). CHIEMESEE, GERMANY: ACADEMIC PRESS INC ELSEVIER SCIENCE.
    DOI Scopus62 WoS56 Europe PMC39
    2002 Hicks, A., Burt, A., Thompson, M., & Day, C. (2002). Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells.. In HEPATOLOGY Vol. 36 (pp. 485A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
    2002 Price, A., Agawal, K., Hewett, M., Craig, W., Schmid, M., Turner, A., . . . Bassendine, M. (2002). The hepatitis C virus (HCV) epidemic; Spectrum of chronic liver disease in a single UK centre.. In HEPATOLOGY Vol. 36 (pp. 554A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
    1997 Dack, C., Day, C., Johnson, S., & Burt, A. (1997). Population kinetics of GFAP-positive cells following experimental acute liver injury. In E. Wisse, D. Knook, & C. Balabaud (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 6 (pp. 59-61). BORDEAUX, FRANCE: KUPFFER CELL FOUNDATION.
    WoS1
    1997 Reeves, H., Dack, C., Day, C., & Burt, A. (1997). beta(1) Integrin expression in hepatic stellate cells from normal and diseased human livers. In E. Wisse, D. Knook, & C. Balabaud (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 6 (pp. 154-155). BORDEAUX, FRANCE: KUPFFER CELL FOUNDATION.
    WoS1
    1994 BURT, A., & MATHEW, J. (1994). CELL-CELL AND CELL-MATRIX INTERACTIONS IN HEPATOCARCINOGENESIS. In G. Tiniakos (Ed.), PROGRESS IN HEPATOLOGY '94 (pp. 73-80). ATHENS, GREECE: BETA MEDICAL PUBLISHERS LTD.
    WoS1
    1993 HINES, J., & BURT, A. (1993). EXPRESSION OF CELLULAR INTEGRINS AND THEIR LIGANDS IN HUMAN LIVER SINUSOIDS DURING ONTOGENY. In D. Knook, & E. Wisse (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 4 (pp. 574-577). KUPFFER CELL FDN, ANTWERP, BELGIUM: KUPFFER CELL FOUNDATION.
    WoS1
    1993 MATHEW, J., & BURT, A. (1993). CELLULAR MECHANISMS OF FIBROGENESIS IN GENETIC HEMOCHROMATOSIS. In D. Knook, & E. Wisse (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 4 (pp. 274-276). KUPFFER CELL FDN, ANTWERP, BELGIUM: KUPFFER CELL FOUNDATION.
    WoS1
    1992 MATHEW, J., JAMES, O., HINES, J., & BURT, A. (1992). QUANTITATIVE-ANALYSIS OF THE PERISINUSOIDAL CELL AND MACROPHAGE RESPONSE TO ACETAMINOPHEN-INDUCED LIVER-INJURY. In A. GRESSNER, & G. RAMADORI (Eds.), MOLECULAR AND CELL BIOLOGY OF LIVER FIBROGENESIS (pp. 358-360). MARBURG, GERMANY: KLUWER ACADEMIC PUBL.
    WoS1
    1992 JOHNSON, S., HILLAN, K., HINES, J., FERRIER, R., & BURT, A. (1992). PROLIFERATION AND PHENOTYPIC MODULATION OF PERISINUSOIDAL (ITO) CELLS FOLLOWING ACUTE LIVER-INJURY - TEMPORAL RELATIONSHIP WITH TGF-BETA-1 EXPRESSION. In B. CLEMENT, & A. GUILLOUZO (Eds.), CELLULAR AND MOLECULAR ASPECTS OF CIRRHOSIS Vol. 216 (pp. 219-222). RENNES, FRANCE: INSERM / JOHN LIBBEY EUROTEXT.
    WoS9
    1991 BURR, A., JOHNSON, S., CARPENTER, M., & BURT, A. (1991). IMMUNOLOCALIZATION OF TRANSFORMING GROWTH FACTOR-ALPHA (TGF-ALPHA) IN REGENERATING LIVER FOLLOWING CHEMICALLY-INDUCED NECROSIS. In K. WOODHOUSE, & M. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 203-210). CARDIFF, WALES: EURAGE BOOK SERVICE.
    1991 AHMED, Q., HINES, J., HARRISON, D., & BURT, A. (1991). EXPRESSION OF MUSCLE-ASSOCIATED CYTOSKELETAL PROTEINS BY HUMAN SINUSOIDAL LIVER-CELLS. In E. WISSE, D. KNOOK, & R. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 203-206). TUCSON, AZ: KUPFFER CELL FOUNDATION.
    WoS5
    1991 GRIFFITHS, M., FERRIER, R., SCHUPPAN, D., & BURT, A. (1991). COLLAGEN TYPE-VI - A COMPONENT OF THE PERISINUSOIDAL EXTRACELLULAR-MATRIX IN HUMAN LIVER. In E. WISSE, D. KNOOK, & R. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 155-160). TUCSON, AZ: KUPFFER CELL FOUNDATION.
    1991 MATHEW, J., WYNNE, H., CATTAN, A., HALL, A., & BURT, A. (1991). EXPRESSION OF GLUTATHIONE S-TRANSFERASES IN THE AGING LIVER. In K. WOODHOUSE, & M. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 173-180). CARDIFF, WALES: EURAGE BOOK SERVICE.
    1991 HINES, J., JOHNSON, S., & BURT, A. (1991). NONPARENCHYMAL CELL RESPONSES DURING THE DEVELOPMENT OF BILIARY-CIRRHOSIS. In K. WOODHOUSE, & M. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 211-217). CARDIFF, WALES: EURAGE BOOK SERVICE.
    1991 BURT, A., AHMED, Q., HINES, J., & LEE, J. (1991). INNERVATION OF HUMAN HEPATIC SINUSOIDS - ALTERATIONS IN LIVER-DISEASE. In E. WISSE, D. KNOOK, & R. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 92-97). TUCSON, AZ: KUPFFER CELL FOUNDATION.
    WoS2
    1986 GOUDIE, B., BURT, A., MACFARLANE, G., BOYLE, P., MACSWEEN, R., & WATKINSON, G. (1986). FACTORS AFFECTING THE PROGNOSIS OF PRIMARY BILIARY-CIRRHOSIS. In GUT Vol. 27 (pp. A622). BRITISH MED JOURNAL PUBL GROUP.
  • Conference Items

    Year Citation
    2017 Houghton, D., Zalewski, P., Cassidy, S., Thoma, C., Hallsworth, K., Avery, L., . . . Trenell, M. (2017). Autonomic function is impaired across the spectrum of NAFLD. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
    DOI
    2017 Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study to evaluate scars after colorectal EMR using NBI with dual focus and underwater technique (uNBI-DF): Interim analysis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    2017 Cheng, L. Z. T. P., Campbell, B., Carneiro, G., Burt, A. D., & Singh, R. (2017). Computer-aided diagnosis (CAD) for characterising colorectal lesions: Initial results of a newly developed software. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    2017 Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study predicting histology in colorectal lesions: Interim analysis of the NICE, JNET and MS classifications. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    WoS1
    2015 Mcpherson, S., Hardy, T., Henderson, E., Allison, M., Ratziu, V., Francque, S., . . . Anstee, Q. (2015). HIGH RATE OF FALSE POSITIVES FOR ADVANCED FIBROSIS WHEN SIMPLE NON-INVASIVE FIBROSIS TESTS ARE USED IN OLDER PATIENTS (>= 65 YEARS) WITH NAFLD. Poster session presented at the meeting of GUT. London, ENGLAND: BMJ PUBLISHING GROUP.
    DOI
    2014 McPherson, S., Henderson, E., Hardy, T., Burt, A. D., Day, C., & Anstee, Q. M. (2014). Natural history of NAFLD: A study of 108 patients with paired liver biopsies. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
    2013 Patman, G., Televantou, D., Whitehead, A., Day, C., Oakley, F., Mann, D., . . . Reeves, H. (2013). MILD STEATOSIS AND IMPAIRED GLUCOSE TOLERANCE ARE ASSOCIATED WITH LIVER CANCER DEVELOPMENT, WHILE PROGRESSION TO NASH INCREASES NUMBER/SIZE IN AN ANIMAL MODEL OF NAFLD. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
    DOI
    2013 Brain, J. G., Masson, S., & Burt, A. D. (2013). Transplantation for ALD: Lessons From the Explant. Poster session presented at the meeting of JOURNAL OF PATHOLOGY. Univ Edinburgh, Div Pathol, Edinburgh, SCOTLAND: WILEY-BLACKWELL.
    2013 Patman, G., Televantou, D., Whitehead, A., Piguet, A. -C., Dufour, J., Day, C., . . . Reeves, H. (2013). SULFATASE-2 (SULF2) EXPRESSED IN HEPATOCYTES AND STROMAL CELLS CONTRIBUTES TO THE DEVELOPMENT OF STEATOSIS, THE PROGRESSION OF NAFLD TO FIBROSIS AND THE ADVANCEMENT OF CANCER. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
    DOI
    2013 Whitehead, A., Patman, G., Cornell, L., Televantou, D., Curtin, N., Day, C., . . . Reeves, H. (2013). A ROLE FOR DNA REPAIR PROTEIN KINASE (DNA-PK) IN THE PROGRESSION OF SIMPLE STEATOSIS TO STEATOHEPATITIS (NASH)?. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
    DOI
    2013 Probert, P., Ebrahimkhani, M., Oakley, F., Burt, A., Mann, D., & Wright, M. (2013). METHAPYRILENE TREATMENT IS A REFINED ALTERNATIVE TO BILE DUCT LIGATION AS A MODEL OF REPRODUCIBLE AND REVERSIBLE PERIPORTAL FIBROSIS IN THE RAT. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
    DOI
    2013 Rutkowski, J. V., Burt, A. D., Leavitt, M. C., Hu, W., Canty, D., & Quinn, A. G. (2013). Co-localization of macrophage aggregation and fibrosis in a rat model of lysosomal acid lipase (LAL) deficiency and the effects of enzyme replacement with SBC-102. Poster session presented at the meeting of MOLECULAR GENETICS AND METABOLISM. Orlando, FL: ACADEMIC PRESS INC ELSEVIER SCIENCE.
    DOI WoS1
    2012 Trembling, P., Parkes, J., Tanwar, S., Burt, A., & Rosenberg, W. (2012). ENHANCED LIVER FIBROSIS TEST ACCURATELY IDENTIFIES LIVER FIBROSIS AND PREDICTS CLINICAL OUTCOMES IN ALCOHOLIC LIVER DISEASE. Poster session presented at the meeting of GUT. B M J PUBLISHING GROUP.
    DOI
    2012 Rutkowski, J., Burt, A. D., Leavitt, M., Hu, W., Canty, D., & Quinn, A. G. (2012). Recombinant Human Lysosomal Acid Lipase Decreases Hepatic Macrophage Aggregates and Colocalized Fibrosis in a Rat Model of Lysosomal Acid Lipase Deficiency. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
    WoS2
    2012 Robinson, S. M., Mann, J., Burt, A. D., Manas, D. M., Mann, D. A., & White, S. A. (2012). Does a pro-thrombotic environment contribute to the development of chemotherapy associated liver injury in patients with colorectal liver metastases?. Poster session presented at the meeting of Abstracts from the Annual Meeting of the Society of Academic and Research Surgery, as published in British Journal of Surgery. Nottingham, England: WILEY-BLACKWELL.
    DOI
    2012 Televantou, D., Hui, K., Lochan, R., Charnley, R., Burt, A., & Reeves, H. (2012). MEMBRANOUS EXPRESSION OF SULFATASE-2 IS ASSOCIATED WITH A POORER PROGNOSIS IN PATIENTS FOLLOWING PANCREATIC CANCER RESECTION. Poster session presented at the meeting of GUT. B M J PUBLISHING GROUP.
    DOI
    2012 Tanwar, S., Trembling, P. M., Hogan, B. J., Thorburn, D., Guha, I. N., Parkes, J., . . . Rosenberg, W. M. (2012). An algorithm combining direct and indirect liver fibrosis tests enhances diagnostic performance for the detection of advanced fibrosis (F3-4) in NAFLD minimising the need for liver biopsy. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
    WoS1
    2012 Robinson, S. M., Koshy, A., Knisely, A., Manas, D. M., Burt, A. D., & White, S. A. (2012). Biliary dysfunction in patients with sinusoidal obstruction syndrome. Poster session presented at the meeting of Abstracts from the Annual Meeting of the Society of Academic and Research Surgery, as published in British Journal of Surgery. Nottingham, England: Wiley-Blackwell.
    DOI
    2012 Masson, S., Emmerson, I., Henderson, E., Fletcher, E., Burt, A. D., Day, C. P., & Stewart, S. F. (2012). Clinical but not histological factors predict long-term prognosis in patients with biopsy proven advanced alcoholic liver disease. Poster session presented at the meeting of Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver, as published in Journal of Hepatology. Barcelona, Spain: Elsevier Ireland.
    DOI
    2012 Brain, J., Thompson, E., Burt, A., & Kirby, J. (2012). Allografts, Immunosupression and Autophagy: A Conspiracy to Fibrose?. Poster session presented at the meeting of JOURNAL OF PATHOLOGY. Univ Sheffield, Acad Unit Pathol, Sheffield, ENGLAND: WILEY-BLACKWELL.
    2012 Trembling, P. M., Parkes, J., Tanwar, S., Burt, A. D., & Rosenberg, W. M. (2012). Enhanced liver fibrosis test accurately identifies liver fibrosis and predicts clinical outcomes in alcoholic liver disease. Poster session presented at the meeting of Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver, as published in Journal of Hepatology. Barcelona, Spain: Elsevier Ireland.
    DOI
    2012 Anstee, Q. M., Darlay, R., Leathart, J. B., Clement, J., Clement, K., Aithal, G. P., . . . Day, C. P. (2012). Genome-Wide Association Analysis Confirms Importance of PNPLA3 and Identifies Novel Variants Associated With Histologically Progressive Steatohepatitis in NAFLD. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
    WoS7
    2012 Dunn, L. J., Shenfine, J., Burt, A. D., Jankowski, J. A., & Griffin, S. M. (2012). Columnar metaplasia in the oesophageal remnant following oesophagectomy - a common occurrence and a valuable insight into the development of Barrett's oesophagus. Poster session presented at the meeting of Abstracts from the International Surgical Congress of the Association-of-Surgeons-of-Great-Britain-and-Ireland (ASGBI),as published in British Journal of Surgery. Liverpool, ENGLAND: Wiley-Blackwell.
    DOI
    2012 Robinson, S. M., Mann, J., Manas, D. M., Burt, A. D., Mann, D. A., & White, S. A. (2012). An experimental model of FOLFOX-induced sinusoidal obstruction syndrome.. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. United States: AMER SOC CLINICAL ONCOLOGY.
    DOI
    1992 Lee, J., Boon, A., Hubscher, S., Hines, J., & Burt, A. (1992). Hepatic reinnervation following orthotopic liver transplantation in man. Poster session presented at the meeting of Journal of Physiology. CAMBRIDGE UNIV PRESS.
Date Grant Amount
October 1986 Scottish Home and Health Department Grant K/MRS/50/C956 - Extracellular matrix protein synthesis in the human liver £56,000
November 1986 Tenovus (Scotland) - The role of sinusoidal cells in protein biosynthesis by the mammalian liver £10,000
November 1986 Kinnear Brown Trust - Towards purchase of Beckman JE-6B elutriator rotor centrifuge £11,000
July 1988 Scottish Home and Health Department Biomedical Research Committee Extracellular matrix protein synthesis in the liver £26,000
December 1989 Newcastle Health Authority Research Committee - Role of transforming growth factor in the response of fat strong cells to liver injury and the induction of experimental hepatic fibrosis £13,976
April 1990 North of England Cancer Research Campaign - Cellular origin of hepatocyte growth factor in liver regeneration and during hepatocarcinogenesis £46,896
May 1990 University Research Committee - Production of monoclonal antibodies to rat liver perisinusoidal cells £6,635
August 1990 Newcastle University Hospital Special Trustees - Intracellular ion measurements for the investigation of cellular pathology £35,566
September 1990 University (Small Grants) Awards - Localisation of peptide growth factors in normal and fibrotic human liver £658
March 1991 Newcastle Health Authority Research Committee - Alterations to intra-hepatic nerves in chronic liver disease and orthotopic liver allografts £15,133
May 1991 North of England Cancer Research Campaign - Cell-matrix interactions in hepato- carcinogenesis £37,550
July 1991 North of England Cancer Research Campaign - DNA repair by O6-methyl guanine DNA methyl transferase: its role in human hepatocarcinogenesis £104,058
November 1992 North of England Cancer Research Campaign - Modulation of cell proliferation in vivo using monoclonal anti-growth factor antibodies £78,697
November 1992 Northern Regional Health Authority - Quantitative assessment of hepatic fibrosis in percutaneous liver biopsy specimens £16,079
June 1993 University Hospital Special Trustees - Risk stratification in hereditary non-polyposis colorectal cancer £30,647
August 1993 University Hospitals Trustees -Integrins and cadherins as prognostic indicators in breast cancer £18,100
February 1994 MRC Clinical Training Fellowship (for Dr. S. Hinchliffe) - Expression of androgen receptor in  human  malignancies:  molecular pathological  studies

£33,075

April 1994 Northern Regional Health Authority - In situ PCR: application to hepatitis C virus infection £25,000
April  1994 Wellbeing/Royal College of Obstetricians and Gynaecologists - The pulmonary interstitium  in  normal  development  and  bronchopulmonary dysplasia  

£23,594

June 1994 Medical Research Council Collaborative PhD Studentship - Modulation of the function of hepatocyte growth factor and its receptor in vivo using antibodies to recombinant proteins £35,000
June 1994 Luccock Faculty Studentship - Cell-matrix interactions and signal transduction pathways in liver perisinusoidal (Ito) cells £24,000
May 1995 North of England Cancer Research Campaign - Alkylation DNA damage and repair £71,000
June 1995 British Lung Foundation - Cell proliferation and programmed cell death in the early human lung development £21,720
June 1995 University Hospital Special Trustees - Endothelin 1 and endothelin receptors in alcoholic liver disease £21,000
July 1995 National Institute of Health (USA) (with Dr JN Bulmer) - Preterm labor: an immune phenomenon? £48,000
February 1996 Freeman Hospital Trustees - Endothelial damage after liver perfusion £1,718
February 1996 Bayer Pharmaceuticals - In vivo inhibition of growth factor activity following injury: image bullets and fibrogenesis £34,700
January 1998 Bayer Pharmaceuticals -Serum markers of liver fibrosis £109,889
July 1998 National Kidney Research Fund - Renal allograft rejection: examination of the basis for tissue specific cytotoxicity £75,000
January 1999 University Hospital Special Trustees - Cell signalling in hepatic stellate cells: role of lipid second messengers £9,700
February 1999 Harker Foundation - Bile duct destruction in autoimmune cholangiopathy £37,500
June 2000 Wellcome Trust-  Biochemical and  functional characterisation of  hepatitis  C  virus particles isolated from human liver and serum £163,593
August 2000 William Harker Foundation - Do apoptotic biliary epithelial cells provide the antigen for induction of autoimmune cholangiopathy? £53,876
August 2001 Cancer Research Campaign - Lymphatic mapping and sentinel node biopsy in the evaluation of the metastatic dissemination of oesophageal adenocarcinoma £43,169
February 2001 Childrens Liver Disease Foundation - The role of bile acids in the regulation of hepatic stellate cell function £75,067
April 2001 Medical Research Council - Use of multiple epidemiological methods to examine clues to environmental causative factors in primary biliary cirrhosis £128,221
December 2002

Newcastle Healthcare Charity - Novel mechanisms of progressive allograft dysfunction

£9,100
June 2003 Roche Organ Transplant Research Foundation - Therapeutic elimination of intraepithelial T cells: a strategy to reduce epithelial-mesenchymal transdifferentiation and chronic allograft dysfunction £125,424
January 2004 National Association for Crohns Disease and Colitis - Histological correlation with genetic variation in Crohns disease

£38,000

February 2007 National Kidney Research Fund - Kidney allograft failure: implications of the imbalance between IL-17 and TGFβ producing intratubular cells £112,070
April 2008 Newcastle Healthcare Charity - Pilot study of the use of antibody to surface proteins on hepatic myofibroblasts in fibrosis imaging £24,725
October 2008 Wellcome Trust - Role of myofibroblasts in liver injury and regeneration £263,000
January 2009 European Commission FP7 - INFLA-CARE Understanding inflammation associated for the rational decision of novel anti-cancer 554,592 euros
July 2009 European Commission FP7 - Fatty Liver Inhibition of Progression (FLIP) European Fatty Liver CRN 5.9 million euros
July 2009 Wellcome Trust Programme Grant - Innate immunity and liver fibrosis (Co-PI with Michael Karin and Derek Mann £690,415
Jan 2015 NHMRC – The role of TRPM2 channels in oxidative stress induced liver damage $558,433
  • Position: Emeritus Professor
  • Email: alastair.burt@adelaide.edu.au
  • Building:
  • Org Unit: Health and Medical Sciences Faculty Office Administration

Connect With Me
External Profiles